Literature DB >> 35256590

ATG7-enhanced impaired autophagy exacerbates acute pancreatitis by promoting regulated necrosis via the miR-30b-5p/CAMKII pathway.

Liang Ji1,2, Zhi-Hong Wang3, Yu-Hua Zhang4,5, Yi Zhou1,2, De-Sheng Tang1,6, Chang-Sheng Yan1,6, Jia-Min Ma1,6, Kun Fang1,6, Lei Gao1,6, Nian-Sheng Ren1,6, Long Cheng1,6, Xiao-Yu Guo1,6, Bei Sun1,6, Gang Wang7,8.   

Abstract

The present study was performed to explore whether and how impaired autophagy could modulate calcium/calmodulin-dependent protein kinase II (CAMKII)-regulated necrosis in the pathogenesis of acute pancreatitis (AP). Wistar rats and AR42J cells were used for AP modeling. When indicated, genetic regulation of CAMKII or ATG7 was performed prior to AP induction. AP-related necrotic injury was positively regulated by the incubation level of CAMKII. ATG7 positively modulated the level of CAMKII and necrosis following AP induction, indicating that there might be a connection between impaired autophagy and CAMKII-regulated necrosis in the pathogenesis of AP. microRNA (miR)-30b-5p was predicted and then verified as the upstream regulator of CAMKII mRNA in our setting of AP. Given that the level of miR-30b-5p was negatively correlated with the incubation levels of ATG7 after AP induction, a rescue experiment was performed and indicated that the miR-30b-5p mimic compromised ATG7 overexpression-induced upregulation of CAMKII-regulated necrosis after AP induction. In conclusion, our results indicate that ATG7-enhanced impaired autophagy exacerbates AP by promoting regulated necrosis via the miR-30b-5p/CAMKII pathway.
© 2022. The Author(s).

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35256590      PMCID: PMC8901675          DOI: 10.1038/s41419-022-04657-4

Source DB:  PubMed          Journal:  Cell Death Dis            Impact factor:   9.685


Introduction

Because the exact underlying mechanism is still far from known and no specific therapy has yet been developed, acute pancreatitis (AP) remains a clinical challenge with considerable morbidity and mortality [1]. Several cell death pathways are evoked and play sophisticated roles in the pathogenesis of AP. Unlike apoptosis, which acts as a self-defense mechanism against AP-related injuries, necrosis usually correlates positively with the severity of AP. For two decades, necrosis was thought to be an accidental passive cell death in response to physiochemical insults. However, increasing evidence has suggested that there might be a series of signaling pathways involved in the regulation of emerging programmed cell death named regulated necrosis [2-4]. Regulated necrosis is defined as a genetically controlled cell death process that eventually results in cellular leakage, and it is morphologically characterized by cytoplasmic granulation, as well as organelle and/or cellular swelling [3]. Regulated necrosis usually consists of necroptosis, pyroptosis, parthanatos, ferroptosis and others. Among these regulated programs, only necroptosis has been relatively well elucidated by the canonical receptor-interacting protein kinase 1 (RIPK1)/RIPK3/mixed lineage kinase domain-like protein pathway. We must admit that there remain many unknowns in the understanding of regulated necrosis. Previously, our results suggested that the inhibition of RIPK1-dependent regulated necrosis provided protection against AP via the RIPK1/NF-κB/aquaporin (AQP) 8 pathway, indicating a new horizon for exploring the mechanism of AP and its possible targeted therapy [5]. Autophagy is a quality control process that serves as a salvage mechanism for recycling cytoplasmic materials and preserving energy via lysosome-driven degradation in response to a series of extracellular and intracellular stresses, including nutrient deprivation, hormonal therapy, pathogenic infection, misfolded proteins and damaged organelles [6]. Fundamental or physiological autophagy is an essential cellular self-aid behavior in a harsh environment and otherwise will lead to cell damage. Two early-phase characteristics in pancreatic acini during AP have long been noticed, namely, the accumulation of cytoplasmic vacuoles and the premature activation of trypsinogen. Recently, evidence has accumulated that both of these pathological responses to AP could be attributed to impaired autophagy, although the potential mechanism is still a debate [7-11]. Our previous report suggested that impaired autophagy in our AP rat model resulted from overactivation of the upstream formation of autophagosomes via the AMPK/mTOR pathway in response to increased levels of incubated hydrogen sulfide [7]. The molecular machinery of autophagy is referred to as ATG genes. ATG7 acts as an ubiquitin-activating enzyme, is required for ATG12–ATG5 conjugation and the subsequent formation of autophagosomes [12]. Intracellular Ca2+ homeostasis is critical for many vital biological processes during AP. In our previous report, the level of intracellular Ca2+ was positively correlated with the extent of cellular energy stress and necrosis after AP induction [13]. Calcium/calmodulin-dependent protein kinase II (CAMKII) is a multifunctional serine/threonine protein kinase that mediates the phosphorylation of its substrates in response to cytoplasmic Ca2+ increase. Therefore, CAMKII could be considered as an indicator of intracellular Ca2+ levels in the setting of AP [14, 15]. Furthermore, CAMKII was found to be indispensable during trypsinogen activation in the AP model induced by nicardipine [15]. In addition to the phosphorylation of its substrate, intersubunit, intraholoenzyme autophosphorylation of CAMKII develops after the entry of Ca2+ into acinar cells and acquires autonomous and Ca2+-independent activity [16]. Therefore, CAMKII might be a promising target in the future management of AP. However, there remain some unrevealed issues before concluding the abovementioned clinical significance of CAMKII. Both the upstream mechanism of CAMKII alteration and the downstream effects imposed on cell death pathways in the setting of AP are unknown according to the only related report [15]. MicroRNAs (miRs) are a group of evolutionarily highly conserved single‐stranded nucleotides of 19–25 nt that negatively regulate gene expression in a sequence-specific manner at the post-transcriptional level [17]. Several miRs are believed to be involved in the pathogenesis of AP through the underlying mechanisms consisting of their regulation of the cell death pathway, local inflammatory response and targeted organ injury [18]. miR-21-5p could regulate necroptosis, a type of regulated necrosis, through a protein inhibitor of the activated STAT 3/STAT3 pathway in AP [19]. The miR-30 family, consisting of miR-30a, miR-30b, miR-30c, miR-30d, miR-30e, and miR-384, is believed to be sophisticated in many inflammatory conditions [20, 21]. The present study was performed to explore whether and how impaired autophagy could modulate the expression of CAMKII and regulated necrosis in the pathogenesis of AP, and thus to shed new light on the future interpretation and management of AP.

Materials and methods

Reagents

Sodium taurocholate (Na-TC) and sodium pentobarbital were purchased from Sigma-Aldrich (St. Louis, MO, USA). Lentiviral vectors encoding ATG7 (Lv-ATG7) or CAMKII (Lv-CAMKII) and lentivirus with scrambled sh-ATG7 (Lv-sh-ATG7) or sh-CAMKII (Lv-sh-CAMKII) were purchased from GeneChem (Shanghai, China). MiR-30b-5p mimic and mimic negative control were purchased from RiboBio (Guangzhou, China). The primary antibodies used for Western blot were microtubule-associated protein 1 light chain 3 (LC3), p62, ATG7 and high mobility group protein B1 (HMGB1) purchased from Cell Signaling Technology (Danvers, MA, USA), tumor necrosis factor α (TNF-α), β-actin and interleukin-1β (IL-1β) purchased from Santa Cruz Biotechnology (Dallas, Texas, USA), CAMKII purchased from Abcam (Shanghai, China), and lysosome-associated membrane protein-2 (LAMP-2) purchased from Thermo Fisher Scientific (Rockford, IL, USA).

Model establishment and ethics statement

Sixty male Wistar rats, weighing 200–250 g, were supplied by the Animal Research Center at the First Affiliated Hospital of Harbin Medical University (Harbin, China). The rat model of AP was established using a previously described method [7, 13]. Briefly, the rats were anaesthetized by an intraperitoneal injection of sodium pentobarbital (40 mg/kg). Then, a midline laparotomy was performed, and the distal pancreaticobiliary duct was ligated. AP was induced by a retrograde infusion of 3.5% Na-TC (0.15 ml/100 g) into the pancreaticobiliary duct. The rats in sham group were subjected to laparotomy alone. The animal care and experimental protocols were all approved by the Institutional Animal Care and Use Committee of Harbin Medical University and conducted in accordance with the Guide for the Care and Use of Laboratory Animals.

Experimental design in vivo

The rats were fed rodent chow and water ad libitum in an environmentally controlled room (18–21 °C, 40–60% relative humidity, 12 h light/dark cycle). After 1 week of acclimatization, the rats were deprived of food overnight before the experiments. Based on our preliminary experiments, an injection of knockdown (106 TU/mL in 200 μL of PBS) or overexpression (5 × 106 TU/mL in 200 μL of PBS) lentivirus vector through the caudal vein 5 days before the experiment was performed to regulate the level of ATG7 or CAMKII in rats. In sham and AP groups, an equivalent volume of the corresponding negative control was administered instead. All of the surviving rats in each group were sacrificed at 6 h after AP induction. For every single blood sample, serum was obtained after centrifugation at 3000 r/min for 15 min and then stored at −80 °C until assayed. Each pancreatic sample was homogeneously prepared for three different purposes: rinsed in saline buffer and snap-frozen in liquid nitrogen at −80 °C for Western blot, fixed in 4% buffered paraformaldehyde for 48 h and then embedded in paraffin for hematoxylin and eosin staining (H&E staining) and immunohistochemistry (IHC), fixed in 2 mL of 2.5% glutaraldehyde and postfixed in 1% osmium tetroxide solution for transmission electron microscopy (TEM).

Measurement of parameters in serum and pancreas

The serum levels of C-reactive protein (CRP) and amylase were spectrophotometrically measured using a biochemical autoanalyzer (Toshiba, Tokyo, Japan) as previously described [5, 13]. The serum levels of TNF-α and IL-1β were measured using enzyme-linked immunosorbent assay kits (R&D Systems, Minneapolis, MN, USA) according to the manufacturer’s instructions. The pancreatic levels of malondialdehyde (MDA), myeloperoxidase (MPO) and lipid peroxidase (LPO) were measured using specific kits (Jiancheng, Nanjing, China) according to the manufacturer’s instructions.

H&E staining

H&E staining was performed to observe the level of inflammation and tissue damage under a light microscope. Two professional pathologists who were blinded to the experimental protocol scored the pancreatic tissue on a scale from 0 to 4 for the degrees of edema, inflammation, hemorrhage and necrosis in 20 randomly selected fields. We applied the scoring system defined by Kusshe et al. [22] and the final score for each group was totaled.

Transmission electron microscopy (TEM)

The fixed samples were dehydrated through a graded series of ethanol and embedded in epoxy resin. Ultrathin sections (80 nm) were collected on copper grids, double-stained with uranyl acetate and lead citrate, and then examined under a Hitachi H-7100 transmission electron microscope (Hitachinaka, Japan) at 80 kV. For quantification, the percentage of autophagic vacuoles (mono- or bilayer membrane structures wrapped around the partially degraded cargos) per cytoplasmic area was calculated on each print [6].

IHC

The protocol for IHC has been previously described [5, 7]. In short, the specimens were dewaxed and incubated with 3% H2O2 in methanol at 37 °C for 10 min to quench endogenous peroxidase. After blocking at room temperature for 30 min, the sections were incubated with CAMKII (1: 200) overnight at 4 °C. Subsequently, the sections were incubated with secondary antibodies (1:200; ZSGB-BIO, Beijing, China) and developed for color with diaminobenzidine peroxidase color development kits (ZSGB-BIO). Finally, the sections were counterstained with hematoxylin. The sections were observed under a light microscope and the expression of protein was quantified by integrated optical density (IOD) with Image-Pro Plus v6.0 software (Media Cybernetics, Crofton, MA, USA) in 20 randomly selected fields. The cells with the presence of a dark reddish-brown chromogen indicate a positive signal.

Cell cultures

The rat pancreatic exocrine cell line AR42J was purchased from the American Type Culture Collection (Manassas, VA, USA) and cultured in Dulbecco’s modified Eagle’s medium (Gibco, Grand Island, NY, USA) supplemented with 10% fetal bovine serum (ScienCell, San Diego, CA, USA), 100 U/mL penicillin and 100 mg/ml streptomycin (Invitrogen, Carlsbad, CA, USA) at 37 °C in a 5% CO2 humidified incubator.

Experimental design in vitro

AR42J cells were seeded into 6-well plates (5 × 104 per well) until 70% confluence so that appropriate volumes of lentivirus could be added to achieve the multiplicity of the infection value recommended by the manufacturer. After lentiviral infection, stable clones were selected with 2 μg/mL puromycin (Sigma-Aldrich) for 2–4 weeks. Alternatively, transfection of the miR-30b-5p mimic (100 nM) was conducted to manipulate the genetic level of miR-30b-5p. The efficiency of all transfections was evaluated by quantitative real-time polymerase chain reaction (qRT-PCR) and/or Western blot. To stimulate AP in vitro, AR42J cells were incubated with 500 μM Na-TC for 3 h as detailed in our previous reports [7, 13]. For control group, the cells were treated with an equivalent volume of PBS to that of Na-TC administered for AP induction.

Adenosine triphosphate (ATP) assays

The ATP contents of pancreatic tissues or cells were measured using an Enhanced ATP Assay Kit (Beyotime, Beijing, China) according to the manufacturer’s instructions, normalized to the protein concentration and finally expressed as nmol/mg.

Mitochondrial transmembrane potential (MTP) assay

Intracellular MTP was determined using the dual-emission mitochondrial dye 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolocarbocyanine iodide (JC-1, Beyotime) as detailed elsewhere [13]. In short, staining was performed using 2.5 μg/mL JC-1 for 15 min at 37 °C. After staining, the cells were rinsed three times with PBS. Dye equilibration was allowed for 10 min at room temperature prior to imaging. Fluorescent images of the emissions at 529 and 590 nm were captured using a laser confocal microscope (Carl Zeiss, Oberkochen, Germany). JC-1 exhibits a fluorescence emission shift upon aggregation from 529 nm (green monomer, indicative of low MTP) to 590 nm (red J-aggregates, indicative of high MTP). Thus, a reduced ratio of red/green fluorescence indicates mitochondrial depolarization.

Measurement of intracellular Ca2+ concentration

The method for the measurement of intracellular Ca2+ concentration has been described previously [13]. In brief, the cells were preloaded with 5 μM Fura-2 AM (Beyotime) in HEPES buffer for 1 h at room temperature. Images of the Fura-2-loaded cells were captured using a laser confocal microscope (Carl Zeiss) and analyzed using Image-Pro Plus v6.0 software. Background-subtracted fluorescent images for excitation at 340 and 380 nm were captured. The intracellular Ca2+ concentration was estimated from the ratio of Fura-2 fluorescence emitted at 510 nm after excitation at 340 nm to that after excitation at 380 nm, according to the Grynkiewicz equation [23].

Necrosis assay

Cell necrosis was detected by an apoptosis and necrosis assay kit (Beyotime) according to the manufacturer’s instructions. Briefly, 105 cells were seeded in 6-well plate and then treated according to the study design. The cells were subjected to the mixed solution consisting of 2 mL dying buffer, 10 μL Hoechst 33342 solution and 10 μL propidium iodide (PI) solution for 30 min at 4 °C. The cells were washed with PBS twice before imaging. The images were acquired using a confocal laser scanning microscope (Carl Zeiss), and the average percentages of necrotic cells (suggested by a duo-fluorescence of red and blue) were calculated in five randomly selected high-power fields.

RNA isolation, reverse transcription, and qRT-PCR

Total RNA extraction and reverse transcription were performed as previously described [5]. qRT-PCR (SYBR Green Assay, Roche, Mannheim, Germany) was performed on Applied Biosystem 7500. Data analysis was performed using the 2−△△CT method. U6 was used as the internal reference for miR-30b-5p, and GADPH was used as the internal reference for CAMKII mRNA. The primer sequences were designed by Primer 5.0 and are listed in Table 1.
Table 1

Primer sequence of genes.

GenePrimer sequence
CAMKIIF: 5′-GACAAGAAAACTCCGCAA-3′
R: 5′-AAATCAACCCCAAAATCC-3′
GADPHF: 5′-TGGAGTCTACTGGCGTCTT-3′
R: 5′-TGTCATATTTCTCGTGGTTCA-3′
miR-30b-5pF: 5′-ACACTCCAGCTGGGTGTAAACATCCTACAC-3′
R: 5′-CTCAACTGGTGTCGTGGAGTCGGCAATTCAGTTGAGAGCTGAGT-3′
U6F: 5′-CTCGCTTCGGCAGCACA-3′
R: 5′-AACGCTTCACGAATTTGCGT-3′

Primer sequence of CAMKII, GADPH, miR-30b-5p and U6.

F forward primer sequence, R reverse primer sequence.

Primer sequence of genes. Primer sequence of CAMKII, GADPH, miR-30b-5p and U6. F forward primer sequence, R reverse primer sequence.

Western blot

The Western blot protocol has been previously described [5, 7, 13]. In brief, pancreatic tissues or cells were homogenized in protein lysate buffer that contained protease inhibitor and phosphatase inhibitor (Roche, Shanghai, China), and debris was removed by centrifugation. The samples were resolved on polyacrylamide sodium dodecyl sulfate gels and electrophoretically transferred to polyvinylidene difluoride membranes. The membranes were blocked with 5% skimmed milk and incubated with the proper primary antibodies (1:1000) and horseradish peroxidase-conjugated secondary antibodies (1:2000, ZSGB-BIO). Immunostained bands were detected using enhanced chemiluminescence kits (Pierce Chemical, Rockford, IL, USA). β-actin (1:1000) was used as the protein loading control.

Autophagy flux assay

To facilitate the autophagy flux assay, AR42J cells were transfected with a mRFP-GFP-LC3 tandem lentivirus (GeneChem) according to the manufacturer’s instructions [7]. Theoretically, GFP is a stably folded protein and relatively resistant to lysosomal proteases. However, the low pH level inside the lysosomes quenches the fluorescent signal of GFP. With this construct, autophagosomes and autolysosomes were labeled with yellow (mRFP and GFP) and red (mRFP only). After treatments, the images of differently allocated cells were captured using a confocal laser scanning microscope (Carl Zeiss) and analyzed using Image-Pro Plus v6.0 software. We calculated the ratio of autolysosomes (red) to autophagosomes (yellow) per cell to evaluate the status of autophagy flux.

Luciferase reporter assay

To determine whether CAMKII acts as a direct target of miR-30b-5p, the 3′-untranslated region (3′-UTR) of wild-type CAMKII (WT) and mutant-CAMKII (MUT) were amplified and then cloned into the pmiR-RB-ReportTM vector (RiboBio). For the luciferase reporter assay, AR42J cells were cotransfected with 50 nM miR-30b-5p or 50 nM miR-control. Luciferase activity was determined using the dual luciferase assay system (Promega, Madison, WI, USA) after 48 h of transfection. Luciferase activity was normalized to Renilla luciferase activity.

Statistical analysis

Data are presented as the mean±standard deviation of at least three independent experiments and were analyzed using SAS 9.1 for Windows (SAS Institute, Cary, NC, USA). The data were analyzed using one-way ANOVA followed by a Scheffe test. A P value of <0.05 was considered statistically significant.

Results

AP-related necrotic injury was positively regulated by the incubation level of CAMKII

The pathomorphological alterations of pancreatic tissues that were subjected to sham, AP, AP + Lv-CAMKII or AP + Lv-sh-CAMKII were observed by H&E staining. A series of necrosis, hemorrhage, edema and inflammatory cell infiltration developed after AP induction, whereas no obvious abnormality was found in sham group. Necrosis was more severe in AP + Lv-CAMKII group and less severe in AP + Lv-sh-CAMKII group than that in AP group. The histological scores were significantly increased after AP induction in comparison to those in sham group. In addition, CAMKII overexpression before AP induction was associated with an increase in histological scores, whereas CAMKII knockdown before AP was associated with a decrease in histological scores compared to that in AP group (Fig. 1A). The measurements of the contents of inflammatory cytokines and other AP-related parameters were in accordance with the findings of H&E staining (Fig. 1B–E and Supplementary Fig. 1). Therefore, AP-related necrotic injury was positively regulated by the incubation level of CAMKII.
Fig. 1

AP-related necrotic injury was positively regulated by the incubation level of CAMKII.

A Representative photographs and histological scores of HE-stained pancreatic sections harvested from the rats that were subjected to sham operation, AP, AP + Lv-CAMKII and AP + Lv-sh-CAMKII for 6 h since AP induction. Bar = 400 μm. B, C Serum levels of amylase, CRP, TNF-α, and IL-1β in rats as described above. D Pancreatic levels of ATP contents, LPO, MPO, and MDA in rats as described above. E Representative Western blot images and quantifications of CAMKII, HMGB1, TNF-α and IL-1β protein expression in pancreatic tissues harvested from the rats as described above. β-actin was used as the protein loading control. Data were presented as mean ± SD (N ≥ 3). P < 0.05 versus sham, P < 0.05 versus AP, and *P < 0.05 versus AP + Lv−CAMKII. AP acute pancreatitis, ATP adenosine triphosphate, CAMKII calcium/calmodulin-dependent protein kinase II, CRP C-reactive protein, HE hematoxylin-eosin, HMGB1 high mobility group protein B1, IL-1β interleukin-1β, LPO lipid peroxidase, MDA malonic dialdehyde, MPO myeloperoxidase, SD standard deviation, TNF-α tumor necrosis factor-α.

AP-related necrotic injury was positively regulated by the incubation level of CAMKII.

A Representative photographs and histological scores of HE-stained pancreatic sections harvested from the rats that were subjected to sham operation, AP, AP + Lv-CAMKII and AP + Lv-sh-CAMKII for 6 h since AP induction. Bar = 400 μm. B, C Serum levels of amylase, CRP, TNF-α, and IL-1β in rats as described above. D Pancreatic levels of ATP contents, LPO, MPO, and MDA in rats as described above. E Representative Western blot images and quantifications of CAMKII, HMGB1, TNF-α and IL-1β protein expression in pancreatic tissues harvested from the rats as described above. β-actin was used as the protein loading control. Data were presented as mean ± SD (N ≥ 3). P < 0.05 versus sham, P < 0.05 versus AP, and *P < 0.05 versus AP + Lv−CAMKII. AP acute pancreatitis, ATP adenosine triphosphate, CAMKII calcium/calmodulin-dependent protein kinase II, CRP C-reactive protein, HE hematoxylin-eosin, HMGB1 high mobility group protein B1, IL-1β interleukin-1β, LPO lipid peroxidase, MDA malonic dialdehyde, MPO myeloperoxidase, SD standard deviation, TNF-α tumor necrosis factor-α.

The extent of AP-related overactivated autophagy was positively regulated by the incubation level of ATG7

Previously, we reported that autophagy was overactivated in our AP model of rats induced by Na-TC [7]. In the present study, we performed TEM to examine the cytoplasmic accumulation of autophagic vacuoles. The percentage of autophagic vacuoles per cytoplasmic area was significantly increased after AP induction, compared with that in sham group. Moreover, ATG7 overexpression significantly potentiated the percentage of autophagic vacuoles per cytoplasmic area, whereas ATG7 knockdown significantly decreased the percentage of autophagic vacuoles per cytoplasmic area compared with that in AP group (Fig. 2A). Moreover, AP induction was associated with an increase in LC3 conversion (LC3 II/I) and a decrease in p62. These alterations could be potentiated by prior ATG7 overexpression to AP induction or compromised by prior ATG7 knockdown to AP induction (Fig. 2B and Supplementary Fig. 2). To rule out the possibility of disordered autophagosome-lysosome fusion or lysosome-driven degradation, a Western blot to determine the expression of LAMP-2 (an indispensable lysosome membrane protein for autophagosome–lysosome fusion) in vivo and an autophagy flux assay to determine the ratio of autolysosomes to autophagosomes per cell in vitro were introduced into the present study. Our results indicated that neither the maturation of autophagosomes nor lysosome-driven degradation was disordered after AP induction, with or without ATG7 modulation (Fig. 2B, C and Supplementary Fig. 2). Additionally, the counts of autophagic dots (autophagosomes and autolysosomes) per cell in the autophagy flux assay in vitro were in accordance with the cytoplasmic accumulation of autophagic vacuoles in TEM observations in vivo. Therefore, our results suggested that the extent of AP-related overactivated autophagy was positively regulated by the incubation level of ATG7.
Fig. 2

The extent of AP-related overactivated autophagy was positively regulated by the incubation level of ATG7.

A Representative TEM photos of pancreatic tissues harvested from the rats that were subjected to sham operation, AP, AP + Lv-ATG7 and AP + Lv-sh-ATG7 for 6 h since AP induction. The percentage of autophagic vacuoles (white arrows) per cytoplasm area was calculated. Bar = 5 μm. B Representative Western blot images and quantifications of ATG7, p62, LAMP-2 protein expression and LC3 conversion in pancreatic tissues as described above. β-actin was used as the protein loading control. C Representative fluorescent photographs of autophagy flux assay in mRFP-GFP-LC3 tagged AR42J cells that were subjected to control, AP, AP + Lv-ATG7 and Lv-sh-ATG7 for 3 h since AP induction. The number of autophagic dots and ratio of red dots (autolysosomes) to yellow dots (autophagosomes) per cell was calculated. Bar = 50 μm. Data were presented as mean ± SD (N ≥ 3). P < 0.05 versus sham or control, P < 0.05 versus AP, and *P < 0.05 versus AP + Lv−ATG7. AP acute pancreatitis, CAMKII calcium/calmodulin-dependent protein kinase II, LAMP-2 lysosome-associated membrane protein-2, LC3 microtubule-associated protein 1 light chain 3, SD standard deviation, TEM transmission electron microscopy.

The extent of AP-related overactivated autophagy was positively regulated by the incubation level of ATG7.

A Representative TEM photos of pancreatic tissues harvested from the rats that were subjected to sham operation, AP, AP + Lv-ATG7 and AP + Lv-sh-ATG7 for 6 h since AP induction. The percentage of autophagic vacuoles (white arrows) per cytoplasm area was calculated. Bar = 5 μm. B Representative Western blot images and quantifications of ATG7, p62, LAMP-2 protein expression and LC3 conversion in pancreatic tissues as described above. β-actin was used as the protein loading control. C Representative fluorescent photographs of autophagy flux assay in mRFP-GFP-LC3 tagged AR42J cells that were subjected to control, AP, AP + Lv-ATG7 and Lv-sh-ATG7 for 3 h since AP induction. The number of autophagic dots and ratio of red dots (autolysosomes) to yellow dots (autophagosomes) per cell was calculated. Bar = 50 μm. Data were presented as mean ± SD (N ≥ 3). P < 0.05 versus sham or control, P < 0.05 versus AP, and *P < 0.05 versus AP + Lv−ATG7. AP acute pancreatitis, CAMKII calcium/calmodulin-dependent protein kinase II, LAMP-2 lysosome-associated membrane protein-2, LC3 microtubule-associated protein 1 light chain 3, SD standard deviation, TEM transmission electron microscopy.

ATG7 positively modulated the levels of CAMKII and necrosis following AP induction

The pancreatic mRNA and protein expression of CAMKII were evaluated by QT-PCR and IHC. Our results indicated that both the mRNA and protein expression of CAMKII were increased in AP group compared to sham group. Moreover, prior ATG7 overexpression to AP induction upregulated both the mRNA and protein expression of CAMKII, whereas prior ATG7 knockdown to AP induction downregulated both the mRNA and protein expression of CAMKII compared to that in AP group (Fig. 3A, B). In vitro, the protein expression of CAMKII detected by Western blot when AR42J cells were subjected to control, AP, AP + Lv-ATG7 and AP + Lv-sh-ATG7 treatments echoed the in vivo results (Fig. 3D and Supplementary Fig. 3). The intracellular concentration of Ca2+, which acts as the upstream stimulus of CAMKII, was measured in vitro. AP induction was associated with an increased intracellular concentration of Ca2+ in comparison to that in control group. Prior ATG7 overexpression to AP induction potentiated the intracellular concentration of Ca2+ but prior ATG7 knockdown to AP induction decreased the intracellular concentration of Ca2+, compared to that in AP group (Fig. 3C). By doing so, we can conclude that ATG7 positively modulated the level of CAMKII. MTP assay using JC-1 and measurements of intracellular ATP contents indicated that there was a functional deficiency in mitochondria after AP induction, and its extent was positively correlated with the incubated level of CAMKII (Fig. 3C, E). To directly determine the effect of CAMKII in regulating necrosis when cells were subjected to control, AP, AP + Lv-ATG7 and AP + Lv-sh-ATG7 treatments, necrosis assays and protein expression of HMGB1 (a well-known member of damage-associated molecular patterns released from the nuclei of necrotic cells) using Western blotting were performed. Our results indicated that necrosis was positively associated with the incubation level of ATG7 (Fig. 3D, F and Supplementary Fig. 3). Therefore, these findings suggested that ATG7 positively modulated the levels of CAMKII and necrosis following AP induction.
Fig. 3

ATG7 positively modulated the levels of CAMKII and necrosis following AP induction.

A Representative IHC photographs of CAMKII expression in pancreatic tissues harvested from the rats as described in Fig. 2A. The corresponding IODs were analyzed with Image-Pro Plus v6.0 software. Bar = 100 μm. B Levels of CAMKII mRNA in pancreatic tissues harvested from the rats as described in Fig. 2A. C Intracellular contents of ATP and Ca2+ in cells that were subjected to control, AP, AP + Lv-ATG7 and Lv-sh-ATG7 for 3 h since AP induction. D Representative Western blot images and quantifications of CAMKII and HMGB1 protein expression in cells mentioned above. β-actin was used as the protein loading control. E Representative fluorescent images indicative of MTP by JC-1 staining in cells mentioned above, and the ratio of red/green fluorescence was calculated to indicate MTP. Bar = 50 μm. F Representative fluorescent images indicative of necrosis and apoptosis by PI-Hoechst 33342 duo-staining in cells mentioned above, and the necrotic cells (indicated by a duo-fluorescence of red and blue) rate was calculated. Bar = 100 μm. Data were presented as mean ± SD (N ≥ 3). P < 0.05 versus sham or control, P < 0.05 versus AP, and *P < 0.05 versus AP + Lv−ATG7. AP acute pancreatitis, ATP adenosine triphosphate, CAMKII calcium/calmodulin-dependent protein kinase II, HMGB1 high mobility group protein B1, IHC immunohistochemistry, IOD integrated optical density, MTP mitochondrial transmembrane potential, PI propidium iodide, SD standard deviation.

ATG7 positively modulated the levels of CAMKII and necrosis following AP induction.

A Representative IHC photographs of CAMKII expression in pancreatic tissues harvested from the rats as described in Fig. 2A. The corresponding IODs were analyzed with Image-Pro Plus v6.0 software. Bar = 100 μm. B Levels of CAMKII mRNA in pancreatic tissues harvested from the rats as described in Fig. 2A. C Intracellular contents of ATP and Ca2+ in cells that were subjected to control, AP, AP + Lv-ATG7 and Lv-sh-ATG7 for 3 h since AP induction. D Representative Western blot images and quantifications of CAMKII and HMGB1 protein expression in cells mentioned above. β-actin was used as the protein loading control. E Representative fluorescent images indicative of MTP by JC-1 staining in cells mentioned above, and the ratio of red/green fluorescence was calculated to indicate MTP. Bar = 50 μm. F Representative fluorescent images indicative of necrosis and apoptosis by PI-Hoechst 33342 duo-staining in cells mentioned above, and the necrotic cells (indicated by a duo-fluorescence of red and blue) rate was calculated. Bar = 100 μm. Data were presented as mean ± SD (N ≥ 3). P < 0.05 versus sham or control, P < 0.05 versus AP, and *P < 0.05 versus AP + Lv−ATG7. AP acute pancreatitis, ATP adenosine triphosphate, CAMKII calcium/calmodulin-dependent protein kinase II, HMGB1 high mobility group protein B1, IHC immunohistochemistry, IOD integrated optical density, MTP mitochondrial transmembrane potential, PI propidium iodide, SD standard deviation.

ATG7 overexpression promoted the activation of CAMKII via miR-30b-5p inhibition

To determine the underlying upstream miR targeting CAMKII in our settings of AP, an online bioinformatic analysis using TargetScan, miRanda and miRbase was first performed. There were six overlapping miRs that bind to the 3′-UTR of CAMKII mRNA in theory: miR-30-5p/384-5p, miR-122-5p, miR-135-5p, miR-145-5p, miR-203-3p and miR-551b-5p. A microarray analysis of miRNA using five pairs of pancreatic tissues of rats with or without AP modeling was performed. Thirty-nine miRs were significantly decreased (fold change < −2, P < 0.05) due to AP modeling. A second overlap between the results of online prediction and microarray analysis was conducted and indicated that miR-30b-5p (a family member of miR-30-5p/384-5p) might serve as the upstream miR in regulating the expression of CAMKII (Fig. 4A). To confirm this hypothesis, we cloned a wild-type or a mutated CAMKII 3′-UTR downstream of the luciferase reporter gene and then performed a luciferase reporter assay. We found that exogenous miR-30b-5p expression significantly decreased the activity of the reporter harboring the wild-type CAMKII 3′-UTR, whereas there was no significant change in the activity of the reporter harboring the mutated CAMKII 3′-UTR (Fig. 4B). Subsequently, we noticed that the level of miR-30b-5p was significantly decreased when AR42J cells were subjected to AP induction. In addition, the level of miR-30b-5p was significantly increased when ATG7 knockdown was performed before AP induction and significantly decreased when ATG7 overexpression was performed before AP induction, compared with that in AP group (Fig. 4C). Therefore, our results indicated that ATG7 overexpression promoted the activation of CAMKII via miR-30b-5p inhibition.
Fig. 4

ATG7 overexpression promoted the activation of CAMKII via miR-30b-5p inhibition.

A An online bioinformatic analysis and a microarray analysis of miRNA using five pairs of pancreatic tissues of rats with or without AP modeling were performed to predict the potential upstream miR targeting CAMKII mRNA. B Relative luciferase activities of the reporters harboring the wild-type (WT) or the mutated (MUT) CAMKII 3′-untranslated region (UTR) that were subjected to miR-30b-5p mimic or negative control. C Relative miR-30b-5p expressions in cells that were subjected to control, AP, AP + Lv-ATG7 and Lv-sh-ATG7 for 3 h since AP induction. Data were presented as mean ± SD (N ≥ 3). P < 0.05 versus control, P < 0.05 versus AP, and *P < 0.05 versus AP + Lv-ATG7. AP acute pancreatitis, CAMKII calcium/calmodulin-dependent protein kinase II, SD standard deviation.

ATG7 overexpression promoted the activation of CAMKII via miR-30b-5p inhibition.

A An online bioinformatic analysis and a microarray analysis of miRNA using five pairs of pancreatic tissues of rats with or without AP modeling were performed to predict the potential upstream miR targeting CAMKII mRNA. B Relative luciferase activities of the reporters harboring the wild-type (WT) or the mutated (MUT) CAMKII 3′-untranslated region (UTR) that were subjected to miR-30b-5p mimic or negative control. C Relative miR-30b-5p expressions in cells that were subjected to control, AP, AP + Lv-ATG7 and Lv-sh-ATG7 for 3 h since AP induction. Data were presented as mean ± SD (N ≥ 3). P < 0.05 versus control, P < 0.05 versus AP, and *P < 0.05 versus AP + Lv-ATG7. AP acute pancreatitis, CAMKII calcium/calmodulin-dependent protein kinase II, SD standard deviation.

The miR-30b-5p mimic compromised ATG7 overexpression-induced upregulation of CAMKII-regulated necrosis

To confirm whether the impaired autophagy induced by ATG7 overexpression could upregulate CAMKII-regulated necrosis via miR-30b-5p inhibition. AR42J cells were subjected to AP, AP + Lv-ATG7, AP + miR-30b-5p mimic and AP + Lv-ATG7 + miR-30b-5p mimic. In accordance with previous findings in the present study, prior ATG7 overexpression to AP induction was not only associated with increased mRNA and protein expression of CAMKII, but also associated with enhanced autophagy, as indicated by decreased expression of p62 and increased LC3 conversion and expression of LAMP-2, compared to AP induction alone. Pre-treatment with the miR-30b-5p mimic in addition to AP induction was associated with a decrease in CAMKII in comparison to that in AP group. More importantly, the expression of CAMKII in AP + Lv-ATG7 + miR-30b-5p mimic group was significantly increased compared to that in AP + miR-30b-5p mimic group but significantly decreased compared to that in AP + Lv-ATG7 group (Fig. 5A–C and Supplementary Fig. 4). The levels of HMGB1 by Western blot, MTP and necrosis assay were performed to check the alterations of CAMKII-regulated necrosis. Our results indicated that the MTP loss and necrosis rate in AP + Lv-ATG7 + miR-30b-5p mimic group were significantly increased compared to those in AP + miR-30b-5p mimic group but significantly decreased compared to those in AP + Lv-ATG7 group (Fig. 5D, E). The same result could be seen when it referred to alterations in the level of HMGB1 (Fig. 5B, C and Supplementary Fig. 4). Therefore, we can conclude that the miR-30b-5p mimic compromised ATG7 overexpression-induced upregulation of CAMKII-regulated necrosis.
Fig. 5

The miR-30b-5p mimic compromised ATG7 overexpression-induced upregulation of CAMKII-regulated necrosis.

A Levels of CAMKII mRNA in cells that were subjected to AP, AP + Lv-ATG7, AP + miR-30b-5p mimic and AP + Lv-ATG7 + miR-30b-5p mimic. B, C Representative Western blot images (B) and quantifications (C) of ATG7, p62, LAMP-2, CAMKII, HMGB1 protein expression and LC3 conversion in cells as described above. β-actin was used as the protein loading control. D–F Representative fluorescent images indicative of MTP by JC-1 staining (D, upper panel, Bar = 50 μm) and those indicative of necrosis and apoptosis by PI-Hoechst 33342 duo-staining (D, lower panel, Bar = 100 μm) in cells mentioned above. The ratio of red/green fluorescence was calculated to indicate MTP (E). The necrotic cells (indicated by a duo-fluorescence of red and blue) rate was calculated (F). Data were presented as mean ± SD (N ≥ 3). P < 0.05 versus AP, P < 0.05 versus AP + Lv-ATG7, and *P < 0.05 versus AP + miR-30b-5p mimic. AP acute pancreatitis, CAMKII calcium/calmodulin-dependent protein kinase II, HMGB1 high mobility group protein B1, LAMP-2 lysosome-associated membrane protein-2, LC3 microtubule-associated protein 1 light chain 3, MTP mitochondrial transmembrane potential, PI propidium iodide, SD standard deviation.

The miR-30b-5p mimic compromised ATG7 overexpression-induced upregulation of CAMKII-regulated necrosis.

A Levels of CAMKII mRNA in cells that were subjected to AP, AP + Lv-ATG7, AP + miR-30b-5p mimic and AP + Lv-ATG7 + miR-30b-5p mimic. B, C Representative Western blot images (B) and quantifications (C) of ATG7, p62, LAMP-2, CAMKII, HMGB1 protein expression and LC3 conversion in cells as described above. β-actin was used as the protein loading control. D–F Representative fluorescent images indicative of MTP by JC-1 staining (D, upper panel, Bar = 50 μm) and those indicative of necrosis and apoptosis by PI-Hoechst 33342 duo-staining (D, lower panel, Bar = 100 μm) in cells mentioned above. The ratio of red/green fluorescence was calculated to indicate MTP (E). The necrotic cells (indicated by a duo-fluorescence of red and blue) rate was calculated (F). Data were presented as mean ± SD (N ≥ 3). P < 0.05 versus AP, P < 0.05 versus AP + Lv-ATG7, and *P < 0.05 versus AP + miR-30b-5p mimic. AP acute pancreatitis, CAMKII calcium/calmodulin-dependent protein kinase II, HMGB1 high mobility group protein B1, LAMP-2 lysosome-associated membrane protein-2, LC3 microtubule-associated protein 1 light chain 3, MTP mitochondrial transmembrane potential, PI propidium iodide, SD standard deviation.

Discussion

AP continues to be a clinical challenge for which no specific treatment has been developed thus far due to its sophisticated pathogenesis. When pancreatic acinar cells are doomed following the attack of AP, several major cell death pathways can be activated, namely, apoptosis, necrosis and autophagy. In contrast to apoptosis acting as a protective cell death pathway, necrosis always acts as a detrimental process and correlates well with the severity of AP. Necrosis is considered as a rapid passive process with no specific signaling control for a long period. However, regulated necrosis, an emerging concept, challenges our past understanding of necrosis. Cell death research was thus revitalized by the understanding that necrosis could occur in a highly regulated and genetically controlled manner [2, 3, 24]. Given that the extent of pancreatic acinar cell necrosis is positively associated with the severity and poor prognosis of AP, the role of regulated necrosis and its potential mechanisms in the pathogenesis of AP are worthy of elucidation. In our previous study, our findings suggested that inhibition of RIPK1-dependent regulated acinar cell necrosis provides protection against AP via the RIPK1/NF-κB/AQP8 pathway [5]. In the setting of AP, the structural and functional integrity of mitochondria is of importance not only for cellular oxidative phosphorylation and energy supply but also for the regulation of necrosis [3, 25–28]. Injury-related stress following the attack of AP could damage various calcium pumps and intracellular calcium storage organelles in pancreatic acinar cells, which subsequently lead to intracellular Ca2+ overload. This is an early-phase event since the onset of AP and contributes extensively to the progression of the disease. Previously, Xiao et al. reported that AP-related injury and energy stress could be ameliorated by alleviating intracellular Ca2+ overload in pancreatic acinar cells [14]. Intracellular Ca2+ overload triggers the constant Ca2+ influx of mitochondria, which accelerates the loss of MTP due to mitochondrial membrane permeabilization as the result of the opening of the mitochondrial membrane permeability transition pore [29, 30]. These alterations directly lead to irreversible structural and functional damage in mitochondria and finally result in a loss of ATP production and increased necrosis [28, 31–33]. CAMKII acts as a multifunctional Ca2+/calmodulin-dependent serine/threonine protein kinase that phosphorylates substrates important in transcription and ion channel regulation in response to increased intracellular Ca2+, plays a crucial role in the regulation of the opening of the mitochondrial membrane permeability transition pore although its downstream target is still unknown [34, 35]. The entry of Ca2+ into the cell leads to the formation of the Ca2+/calmodulin complex in a cooperative form. The Ca2+/calmodulin complex binds to the regulatory region of CAMKII and produces a conformational change, which not only phosphorylates its substrates but also leads to autophosphorylation itself to prevent the enzyme from reverting to its inactive conformation and decrease the dissociation rate of the bound calmodulin. Autophosphorylated CAMKII can remain active even when the level of intracellular Ca2+ is decreased and therefore acquire autonomous and Ca2+ independent activity [16]. Sustained, excessive CAMKII activation is an upstream signaling event for constant intracellular Ca2+ overload and mitochondrial Ca2+ uptake, inducing the loss of intracellular Ca2+ homeostasis [36]. In the present study, our results (Fig. 1) suggested that AP-related necrotic injury was positively regulated by the incubation level of CAMKII. Therefore, CAMKII might be a promising therapeutic target in the future management of AP by maintaining the structural and functional integrity of mitochondria in response to increased levels of intracellular Ca2+. MiRs are small noncoding RNAs that bind to mRNAs of target genes at the 3′-UTR, leading to degradation or inhibition of the target mRNAs. MiR, acts as an important mediator in response to various stresses and is involved in signal transductions in response to hypoxia, inflammation and so forth [37-39]. In the present study, an online bioinformatic analysis and a microarray analysis of miRNA using five pairs of pancreatic tissues of rats with or without AP modeling were performed to screen the potential upstream miR that targeted CAMKII. A luciferase reporter assay was then performed and confirmed that miR-30b-5p acts as a negative regulator of CAMKII in our AP models (Fig. 4A, B). Autophagy acts as a self-aid process by recycling cytoplasmic materials and preserving energy via lysosome-driven degradation in response to various stresses. Regardless of the different potential mechanisms due to the variety of AP models, the impaired autophagy is consistently considered to play a significant role in the pathogenesis of AP [7-10]. Previously, our report suggested that autophagy was overactivated via AMPK/mTOR signaling and positively correlated with AP-related injury in our AP model induced by Na-TC [7]. Nevertheless, several cell death pathways might be simultaneously or sequentially activated since the onset of AP. To our knowledge, the interactions and switches among these cell death pathways are sophisticated in the pathogenesis of AP [13, 25, 40]. Therefore, it might not be rational to explore the mechanisms of AP with one single cell death pathway alone. As stretching research following our previous publications, the present research was performed to determine whether and how impaired autophagy could modulate the expression of CAMKII and regulated necrosis, aiming to elucidate the mechanism of AP more comprehensively through a specific focus on impaired autophagy-regulated necrosis interactions and to shed a new light on the future management of AP. The core autophagic machinery is composed of ATG protein constituents. One particular member of the ATG protein family, ATG7, acts as an E1-like activating enzyme facilitating both LC3-phosphatidylethanolamine and ATG12 conjugation. Thus, ATG7 stands at the hub of these two ubiquitin-like systems involving LC3 and ATG12 in autophagic vesicle expansion to facilitate the final step of autophagosome formation [41]. Given that the impaired autophagy in our AP model was derived from an overactivation of autophagy or so-called increased activity of the upstream autophagic pathway, genetic regulation of ATG7 was introduced into the present study to determine whether and how impaired autophagy could regulate CAMKII-regulated necrosis. First, we confirmed that the activity of overactivated upstream autophagic pathway in our AP model was positively correlated with the incubation level of ATG7 (Fig. 2). Our results indicated that the levels of CAMKII, MTP loss and necrosis of acinar cells after AP induction were all positively correlated with the incubation level of ATG7 (Fig. 3). Given that miR-30b-5p acts as a negative regulator of CAMKII in our AP models, the levels of miR-30b-5p in cells subjected to control, AP, AP + Lv-ATG7 and AP + Lv-sh-ATG7 were measured. The results indicated that ATG7 could negatively regulate the level of miR-30b-5p (Fig. 4C). Hinted by these findings, we hypothesized that there might be a novel pathway, ATG7/miR-30b-5p/CAMKII, that establishes a bridge between autophagy and necrosis and is sophisticated in the pathogenesis of AP. A rescue experiment was therefore designed, and its results suggested that the miR-30b-5p mimic compromised ATG7 overexpression-induced upregulation of CAMKII-regulated necrosis in our AP models (Fig. 5). As an emerging programmed cell death pathway, regulated necrosis is being studied regarding its pathophysiological involvement and potential clinical relevance in many diseases [3, 4]. Although the mechanisms of AP are still far from known, our results might serve as a preliminary endeavor to unseal Pandora’s box with a specific horizon on impaired autophagy-regulated necrosis interactions. Both miR-30b-5p and CAMKII could potentially be developed as biomarkers that indicate the severity of AP and, furthermore, as readouts that indicate response to the targeted therapy. However, there was a drawback in the present study. The impaired autophagy in our AP model of rats induced by Na-TC was due to the upstream overactivated formation of autophagosomes [7]. Therefore, it is certain that genetic overexpression of ATG7 after AP establishment would lead to more severe impaired autophagy and illness of the disease. However, it is difficult to point out to what extent ATG7 should be silenced when we aim to provide some protection against AP-related damage. ATG7 plays a significant role in the initiation of autophagosome formation. We should not convert the former impaired autophagy derived from the overactivation of upstream formative pathway in response to AP modeling to the latter one derived from insufficient activity of autophagy, given that the basal physiological activity of autophagy in response to AP modeling is indispensable to provide some protection [42, 43]. The ideal range of activated autophagy in response to AP modeling, which may be suggested by some well-quantified parameters, is worthy of elucidation in future studies. In conclusion, our results indicated that ATG7-enhanced impaired autophagy exacerbates AP by promoting regulated necrosis via the miR-30b-5p/CAMKII pathway. Some specific studies regarding the uncanonical ATG7/miR-30b-5p/CAMKII pathway might be promising in the future management of AP (Fig. 6).
Fig. 6

Schematic presentation of the mechanism involved in the promotion of regulated necrosis in response to ATG7-enhanced impaired autophagy in our AP model.

AP acute pancreatitis, ATP adenosine triphosphate, CAMKII calcium/calmodulin-dependent protein kinase II, HMGB1 high mobility group protein B1, Na-TC sodium taurocholate.

Schematic presentation of the mechanism involved in the promotion of regulated necrosis in response to ATG7-enhanced impaired autophagy in our AP model.

AP acute pancreatitis, ATP adenosine triphosphate, CAMKII calcium/calmodulin-dependent protein kinase II, HMGB1 high mobility group protein B1, Na-TC sodium taurocholate. Supplementary Figures Legend Supplementary Figures Ethics Approval aj-checklist
  41 in total

Review 1.  New insights into acute pancreatitis.

Authors:  Peter J Lee; Georgios I Papachristou
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-08       Impact factor: 46.802

Review 2.  Regulated necrosis: the expanding network of non-apoptotic cell death pathways.

Authors:  Tom Vanden Berghe; Andreas Linkermann; Sandrine Jouan-Lanhouet; Henning Walczak; Peter Vandenabeele
Journal:  Nat Rev Mol Cell Biol       Date:  2014-02       Impact factor: 94.444

3.  Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase.

Authors:  Liming Sun; Huayi Wang; Zhigao Wang; Sudan He; She Chen; Daohong Liao; Lai Wang; Jiacong Yan; Weilong Liu; Xiaoguang Lei; Xiaodong Wang
Journal:  Cell       Date:  2012-01-20       Impact factor: 41.582

Review 4.  Regulated necrosis: disease relevance and therapeutic opportunities.

Authors:  Marcus Conrad; José Pedro Friedmann Angeli; Peter Vandenabeele; Brent R Stockwell
Journal:  Nat Rev Drug Discov       Date:  2016-01-18       Impact factor: 84.694

5.  Impaired autophagic flux mediates acinar cell vacuole formation and trypsinogen activation in rodent models of acute pancreatitis.

Authors:  Olga A Mareninova; Kip Hermann; Samuel W French; Mark S O'Konski; Stephen J Pandol; Paul Webster; Ann H Erickson; Nobuhiko Katunuma; Fred S Gorelick; Ilya Gukovsky; Anna S Gukovskaya
Journal:  J Clin Invest       Date:  2009-10-01       Impact factor: 14.808

6.  Interleukin-22 ameliorates cerulein-induced pancreatitis in mice by inhibiting the autophagic pathway.

Authors:  Dechun Feng; Ogyi Park; Svetlana Radaeva; Hua Wang; Shi Yin; Xiaoni Kong; Mingquan Zheng; Sam Zakhari; Jay K Kolls; Bin Gao
Journal:  Int J Biol Sci       Date:  2012-01-06       Impact factor: 6.580

7.  Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1.

Authors:  Daniel J Klionsky; Amal Kamal Abdel-Aziz; Sara Abdelfatah; Mahmoud Abdellatif; Asghar Abdoli; Steffen Abel; Hagai Abeliovich; Marie H Abildgaard; Yakubu Princely Abudu; Abraham Acevedo-Arozena; Iannis E Adamopoulos; Khosrow Adeli; Timon E Adolph; Annagrazia Adornetto; Elma Aflaki; Galila Agam; Anupam Agarwal; Bharat B Aggarwal; Maria Agnello; Patrizia Agostinis; Javed N Agrewala; Alexander Agrotis; Patricia V Aguilar; S Tariq Ahmad; Zubair M Ahmed; Ulises Ahumada-Castro; Sonja Aits; Shu Aizawa; Yunus Akkoc; Tonia Akoumianaki; Hafize Aysin Akpinar; Ahmed M Al-Abd; Lina Al-Akra; Abeer Al-Gharaibeh; Moulay A Alaoui-Jamali; Simon Alberti; Elísabet Alcocer-Gómez; Cristiano Alessandri; Muhammad Ali; M Abdul Alim Al-Bari; Saeb Aliwaini; Javad Alizadeh; Eugènia Almacellas; Alexandru Almasan; Alicia Alonso; Guillermo D Alonso; Nihal Altan-Bonnet; Dario C Altieri; Élida M C Álvarez; Sara Alves; Cristine Alves da Costa; Mazen M Alzaharna; Marialaura Amadio; Consuelo Amantini; Cristina Amaral; Susanna Ambrosio; Amal O Amer; Veena Ammanathan; Zhenyi An; Stig U Andersen; Shaida A Andrabi; Magaiver Andrade-Silva; Allen M Andres; Sabrina Angelini; David Ann; Uche C Anozie; Mohammad Y Ansari; Pedro Antas; Adam Antebi; Zuriñe Antón; Tahira Anwar; Lionel Apetoh; Nadezda Apostolova; Toshiyuki Araki; Yasuhiro Araki; Kohei Arasaki; Wagner L Araújo; Jun Araya; Catherine Arden; Maria-Angeles Arévalo; Sandro Arguelles; Esperanza Arias; Jyothi Arikkath; Hirokazu Arimoto; Aileen R Ariosa; Darius Armstrong-James; Laetitia Arnauné-Pelloquin; Angeles Aroca; Daniela S Arroyo; Ivica Arsov; Rubén Artero; Dalia Maria Lucia Asaro; Michael Aschner; Milad Ashrafizadeh; Osnat Ashur-Fabian; Atanas G Atanasov; Alicia K Au; Patrick Auberger; Holger W Auner; Laure Aurelian; Riccardo Autelli; Laura Avagliano; Yenniffer Ávalos; Sanja Aveic; Célia Alexandra Aveleira; Tamar Avin-Wittenberg; Yucel Aydin; Scott Ayton; Srinivas Ayyadevara; Maria Azzopardi; Misuzu Baba; Jonathan M Backer; Steven K Backues; Dong-Hun Bae; Ok-Nam Bae; Soo Han Bae; Eric H Baehrecke; Ahruem Baek; Seung-Hoon Baek; Sung Hee Baek; Giacinto Bagetta; Agnieszka Bagniewska-Zadworna; Hua Bai; Jie Bai; Xiyuan Bai; Yidong Bai; Nandadulal Bairagi; Shounak Baksi; Teresa Balbi; Cosima T Baldari; Walter Balduini; Andrea Ballabio; Maria Ballester; Salma Balazadeh; Rena Balzan; Rina Bandopadhyay; Sreeparna Banerjee; Sulagna Banerjee; Ágnes Bánréti; Yan Bao; Mauricio S Baptista; Alessandra Baracca; Cristiana Barbati; Ariadna Bargiela; Daniela Barilà; Peter G Barlow; Sami J Barmada; Esther Barreiro; George E Barreto; Jiri Bartek; Bonnie Bartel; Alberto Bartolome; Gaurav R Barve; Suresh H Basagoudanavar; Diane C Bassham; Robert C Bast; Alakananda Basu; Henri Batoko; Isabella Batten; Etienne E Baulieu; Bradley L Baumgarner; Jagadeesh Bayry; Rupert Beale; Isabelle Beau; Florian Beaumatin; Luiz R G Bechara; George R Beck; Michael F Beers; Jakob Begun; Christian Behrends; Georg M N Behrens; Roberto Bei; Eloy Bejarano; Shai Bel; Christian Behl; Amine Belaid; Naïma Belgareh-Touzé; Cristina Bellarosa; Francesca Belleudi; Melissa Belló Pérez; Raquel Bello-Morales; Jackeline Soares de Oliveira Beltran; Sebastián Beltran; Doris Mangiaracina Benbrook; Mykolas Bendorius; Bruno A Benitez; Irene Benito-Cuesta; Julien Bensalem; Martin W Berchtold; Sabina Berezowska; Daniele Bergamaschi; Matteo Bergami; Andreas Bergmann; Laura Berliocchi; Clarisse Berlioz-Torrent; Amélie Bernard; Lionel Berthoux; Cagri G Besirli; Sebastien Besteiro; Virginie M Betin; Rudi Beyaert; Jelena S Bezbradica; Kiran Bhaskar; Ingrid Bhatia-Kissova; Resham Bhattacharya; Sujoy Bhattacharya; Shalmoli Bhattacharyya; Md Shenuarin Bhuiyan; Sujit Kumar Bhutia; Lanrong Bi; Xiaolin Bi; Trevor J Biden; Krikor Bijian; Viktor A Billes; Nadine Binart; Claudia Bincoletto; Asa B Birgisdottir; Geir Bjorkoy; Gonzalo Blanco; Ana Blas-Garcia; Janusz Blasiak; Robert Blomgran; Klas Blomgren; Janice S Blum; Emilio Boada-Romero; Mirta Boban; Kathleen Boesze-Battaglia; Philippe Boeuf; Barry Boland; Pascale Bomont; Paolo Bonaldo; Srinivasa Reddy Bonam; Laura Bonfili; Juan S Bonifacino; Brian A Boone; Martin D Bootman; Matteo Bordi; Christoph Borner; Beat C Bornhauser; Gautam Borthakur; Jürgen Bosch; Santanu Bose; Luis M Botana; Juan Botas; Chantal M Boulanger; Michael E Boulton; Mathieu Bourdenx; Benjamin Bourgeois; Nollaig M Bourke; Guilhem Bousquet; Patricia Boya; Peter V Bozhkov; Luiz H M Bozi; Tolga O Bozkurt; Doug E Brackney; Christian H Brandts; Ralf J Braun; Gerhard H Braus; Roberto Bravo-Sagua; José M Bravo-San Pedro; Patrick Brest; Marie-Agnès Bringer; Alfredo Briones-Herrera; V Courtney Broaddus; Peter Brodersen; Jeffrey L Brodsky; Steven L Brody; Paola G Bronson; Jeff M Bronstein; Carolyn N Brown; Rhoderick E Brown; Patricia C Brum; John H Brumell; Nicola Brunetti-Pierri; Daniele Bruno; Robert J Bryson-Richardson; Cecilia Bucci; Carmen Buchrieser; Marta Bueno; Laura Elisa Buitrago-Molina; Simone Buraschi; Shilpa Buch; J Ross Buchan; Erin M Buckingham; Hikmet Budak; Mauricio Budini; Geert Bultynck; Florin Burada; Joseph R Burgoyne; M Isabel Burón; Victor Bustos; Sabrina Büttner; Elena Butturini; Aaron Byrd; Isabel Cabas; Sandra Cabrera-Benitez; Ken Cadwell; Jingjing Cai; Lu Cai; Qian Cai; Montserrat Cairó; Jose A Calbet; Guy A Caldwell; Kim A Caldwell; Jarrod A Call; Riccardo Calvani; Ana C Calvo; Miguel Calvo-Rubio Barrera; Niels Os Camara; Jacques H Camonis; Nadine Camougrand; Michelangelo Campanella; Edward M Campbell; François-Xavier Campbell-Valois; Silvia Campello; Ilaria Campesi; Juliane C Campos; Olivier Camuzard; Jorge Cancino; Danilo Candido de Almeida; Laura Canesi; Isabella Caniggia; Barbara Canonico; Carles Cantí; Bin Cao; Michele Caraglia; Beatriz Caramés; Evie H Carchman; Elena Cardenal-Muñoz; Cesar Cardenas; Luis Cardenas; Sandra M Cardoso; Jennifer S Carew; Georges F Carle; Gillian Carleton; Silvia Carloni; Didac Carmona-Gutierrez; Leticia A Carneiro; Oliana Carnevali; Julian M Carosi; Serena Carra; Alice Carrier; Lucie Carrier; Bernadette Carroll; A Brent Carter; Andreia Neves Carvalho; Magali Casanova; Caty Casas; Josefina Casas; Chiara Cassioli; Eliseo F Castillo; Karen Castillo; Sonia Castillo-Lluva; Francesca Castoldi; Marco Castori; Ariel F Castro; Margarida Castro-Caldas; Javier Castro-Hernandez; Susana Castro-Obregon; Sergio D Catz; Claudia Cavadas; Federica Cavaliere; Gabriella Cavallini; Maria Cavinato; Maria L Cayuela; Paula Cebollada Rica; Valentina Cecarini; Francesco Cecconi; Marzanna Cechowska-Pasko; Simone Cenci; Victòria Ceperuelo-Mallafré; João J Cerqueira; Janete M Cerutti; Davide Cervia; Vildan Bozok Cetintas; Silvia Cetrullo; Han-Jung Chae; Andrei S Chagin; Chee-Yin Chai; Gopal Chakrabarti; Oishee Chakrabarti; Tapas Chakraborty; Trinad Chakraborty; Mounia Chami; Georgios Chamilos; David W Chan; Edmond Y W Chan; Edward D Chan; H Y Edwin Chan; Helen H Chan; Hung Chan; Matthew T V Chan; Yau Sang Chan; Partha K Chandra; Chih-Peng Chang; Chunmei Chang; Hao-Chun Chang; Kai Chang; Jie Chao; Tracey Chapman; Nicolas Charlet-Berguerand; Samrat Chatterjee; Shail K Chaube; Anu Chaudhary; Santosh Chauhan; Edward Chaum; Frédéric Checler; Michael E Cheetham; Chang-Shi Chen; Guang-Chao Chen; Jian-Fu Chen; Liam L Chen; Leilei Chen; Lin Chen; Mingliang Chen; Mu-Kuan Chen; Ning Chen; Quan Chen; Ruey-Hwa Chen; Shi Chen; Wei Chen; Weiqiang Chen; Xin-Ming Chen; Xiong-Wen Chen; Xu Chen; Yan Chen; Ye-Guang Chen; Yingyu Chen; Yongqiang Chen; Yu-Jen Chen; Yue-Qin Chen; Zhefan Stephen Chen; Zhi Chen; Zhi-Hua Chen; Zhijian J Chen; Zhixiang Chen; Hanhua Cheng; Jun Cheng; Shi-Yuan Cheng; Wei Cheng; Xiaodong Cheng; Xiu-Tang Cheng; Yiyun Cheng; Zhiyong Cheng; Zhong Chen; Heesun Cheong; Jit Kong Cheong; Boris V Chernyak; Sara Cherry; Chi Fai Randy Cheung; Chun Hei Antonio Cheung; King-Ho Cheung; Eric Chevet; Richard J Chi; Alan Kwok Shing Chiang; Ferdinando Chiaradonna; Roberto Chiarelli; Mario Chiariello; Nathalia Chica; Susanna Chiocca; Mario Chiong; Shih-Hwa Chiou; Abhilash I Chiramel; Valerio Chiurchiù; Dong-Hyung Cho; Seong-Kyu Choe; Augustine M K Choi; Mary E Choi; Kamalika Roy Choudhury; Norman S Chow; Charleen T Chu; Jason P Chua; John Jia En Chua; Hyewon Chung; Kin Pan Chung; Seockhoon Chung; So-Hyang Chung; Yuen-Li Chung; Valentina Cianfanelli; Iwona A Ciechomska; Mariana Cifuentes; Laura Cinque; Sebahattin Cirak; Mara Cirone; Michael J Clague; Robert Clarke; Emilio Clementi; Eliana M Coccia; Patrice Codogno; Ehud Cohen; Mickael M Cohen; Tania Colasanti; Fiorella Colasuonno; Robert A Colbert; Anna Colell; Miodrag Čolić; Nuria S Coll; Mark O Collins; María I Colombo; Daniel A Colón-Ramos; Lydie Combaret; Sergio Comincini; Márcia R Cominetti; Antonella Consiglio; Andrea Conte; Fabrizio Conti; Viorica Raluca Contu; Mark R Cookson; Kevin M Coombs; Isabelle Coppens; Maria Tiziana Corasaniti; Dale P Corkery; Nils Cordes; Katia Cortese; Maria do Carmo Costa; Sarah Costantino; Paola Costelli; Ana Coto-Montes; Peter J Crack; Jose L Crespo; Alfredo Criollo; Valeria Crippa; Riccardo Cristofani; Tamas Csizmadia; Antonio Cuadrado; Bing Cui; Jun Cui; Yixian Cui; Yong Cui; Emmanuel Culetto; Andrea C Cumino; Andrey V Cybulsky; Mark J Czaja; Stanislaw J Czuczwar; Stefania D'Adamo; Marcello D'Amelio; Daniela D'Arcangelo; Andrew C D'Lugos; Gabriella D'Orazi; James A da Silva; Hormos Salimi Dafsari; Ruben K Dagda; Yasin Dagdas; Maria Daglia; Xiaoxia Dai; Yun Dai; Yuyuan Dai; Jessica Dal Col; Paul Dalhaimer; Luisa Dalla Valle; Tobias Dallenga; Guillaume Dalmasso; Markus Damme; Ilaria Dando; Nico P Dantuma; April L Darling; Hiranmoy Das; Srinivasan Dasarathy; Santosh K Dasari; Srikanta Dash; Oliver Daumke; Adrian N Dauphinee; Jeffrey S Davies; Valeria A Dávila; Roger J Davis; Tanja Davis; Sharadha Dayalan Naidu; Francesca De Amicis; Karolien De Bosscher; Francesca De Felice; Lucia De Franceschi; Chiara De Leonibus; Mayara G de Mattos Barbosa; Guido R Y De Meyer; Angelo De Milito; Cosimo De Nunzio; Clara De Palma; Mauro De Santi; Claudio De Virgilio; Daniela De Zio; Jayanta Debnath; Brian J DeBosch; Jean-Paul Decuypere; Mark A Deehan; Gianluca Deflorian; James DeGregori; Benjamin Dehay; Gabriel Del Rio; Joe R Delaney; Lea M D Delbridge; Elizabeth Delorme-Axford; M Victoria Delpino; Francesca Demarchi; Vilma Dembitz; Nicholas D Demers; Hongbin Deng; Zhiqiang Deng; Joern Dengjel; Paul Dent; Donna Denton; Melvin L DePamphilis; Channing J Der; Vojo Deretic; Albert Descoteaux; Laura Devis; Sushil Devkota; Olivier Devuyst; Grant Dewson; Mahendiran Dharmasivam; Rohan Dhiman; Diego di Bernardo; Manlio Di Cristina; Fabio Di Domenico; Pietro Di Fazio; Alessio Di Fonzo; Giovanni Di Guardo; Gianni M Di Guglielmo; Luca Di Leo; Chiara Di Malta; Alessia Di Nardo; Martina Di Rienzo; Federica Di Sano; George Diallinas; Jiajie Diao; Guillermo Diaz-Araya; Inés Díaz-Laviada; Jared M Dickinson; Marc Diederich; Mélanie Dieudé; Ivan Dikic; Shiping Ding; Wen-Xing Ding; Luciana Dini; Jelena Dinić; Miroslav Dinic; Albena T Dinkova-Kostova; Marc S Dionne; Jörg H W Distler; Abhinav Diwan; Ian M C Dixon; Mojgan Djavaheri-Mergny; Ina Dobrinski; Oxana Dobrovinskaya; Radek Dobrowolski; Renwick C J Dobson; Jelena Đokić; Serap Dokmeci Emre; Massimo Donadelli; Bo Dong; Xiaonan Dong; Zhiwu Dong; Gerald W Dorn Ii; Volker Dotsch; Huan Dou; Juan Dou; Moataz Dowaidar; Sami Dridi; Liat Drucker; Ailian Du; Caigan Du; Guangwei Du; Hai-Ning Du; Li-Lin Du; André du Toit; Shao-Bin Duan; Xiaoqiong Duan; Sónia P Duarte; Anna Dubrovska; Elaine A Dunlop; Nicolas Dupont; Raúl V Durán; Bilikere S Dwarakanath; Sergey A Dyshlovoy; Darius Ebrahimi-Fakhari; Leopold Eckhart; Charles L Edelstein; Thomas Efferth; Eftekhar Eftekharpour; Ludwig Eichinger; Nabil Eid; Tobias Eisenberg; N Tony Eissa; Sanaa Eissa; Miriam Ejarque; Abdeljabar El Andaloussi; Nazira El-Hage; Shahenda El-Naggar; Anna Maria Eleuteri; Eman S El-Shafey; Mohamed Elgendy; Aristides G Eliopoulos; María M Elizalde; Philip M Elks; Hans-Peter Elsasser; Eslam S Elsherbiny; Brooke M Emerling; N C Tolga Emre; Christina H Eng; Nikolai Engedal; Anna-Mart Engelbrecht; Agnete S T Engelsen; Jorrit M Enserink; Ricardo Escalante; Audrey Esclatine; Mafalda Escobar-Henriques; Eeva-Liisa Eskelinen; Lucile Espert; Makandjou-Ola Eusebio; Gemma Fabrias; Cinzia Fabrizi; Antonio Facchiano; Francesco Facchiano; Bengt Fadeel; Claudio Fader; Alex C Faesen; W Douglas Fairlie; Alberto Falcó; Bjorn H Falkenburger; Daping Fan; Jie Fan; Yanbo Fan; Evandro F Fang; Yanshan Fang; Yognqi Fang; Manolis Fanto; Tamar Farfel-Becker; Mathias Faure; Gholamreza Fazeli; Anthony O Fedele; Arthur M Feldman; Du Feng; Jiachun Feng; Lifeng Feng; Yibin Feng; Yuchen Feng; Wei Feng; Thais Fenz Araujo; Thomas A Ferguson; Álvaro F Fernández; Jose C Fernandez-Checa; Sonia Fernández-Veledo; Alisdair R Fernie; Anthony W Ferrante; Alessandra Ferraresi; Merari F Ferrari; Julio C B Ferreira; Susan Ferro-Novick; Antonio Figueras; Riccardo Filadi; Nicoletta Filigheddu; Eduardo Filippi-Chiela; Giuseppe Filomeni; Gian Maria Fimia; Vittorio Fineschi; Francesca Finetti; Steven Finkbeiner; Edward A Fisher; Paul B Fisher; Flavio Flamigni; Steven J Fliesler; Trude H Flo; Ida Florance; Oliver Florey; Tullio Florio; Erika Fodor; Carlo Follo; Edward A Fon; Antonella Forlino; Francesco Fornai; Paola Fortini; Anna Fracassi; Alessandro Fraldi; Brunella Franco; Rodrigo Franco; Flavia Franconi; Lisa B Frankel; Scott L Friedman; Leopold F Fröhlich; Gema Frühbeck; Jose M Fuentes; Yukio Fujiki; Naonobu Fujita; Yuuki Fujiwara; Mitsunori Fukuda; Simone Fulda; Luc Furic; Norihiko Furuya; Carmela Fusco; Michaela U Gack; Lidia Gaffke; Sehamuddin Galadari; Alessia Galasso; Maria F Galindo; Sachith Gallolu Kankanamalage; Lorenzo Galluzzi; Vincent Galy; Noor Gammoh; Boyi Gan; Ian G Ganley; Feng Gao; Hui Gao; Minghui Gao; Ping Gao; Shou-Jiang Gao; Wentao Gao; Xiaobo Gao; Ana Garcera; Maria Noé Garcia; Verónica E Garcia; Francisco García-Del Portillo; Vega Garcia-Escudero; Aracely Garcia-Garcia; Marina Garcia-Macia; Diana García-Moreno; Carmen Garcia-Ruiz; Patricia García-Sanz; Abhishek D Garg; Ricardo Gargini; Tina Garofalo; Robert F Garry; Nils C Gassen; Damian Gatica; Liang Ge; Wanzhong Ge; Ruth Geiss-Friedlander; Cecilia Gelfi; Pascal Genschik; Ian E Gentle; Valeria Gerbino; Christoph Gerhardt; Kyla Germain; Marc Germain; David A Gewirtz; Elham Ghasemipour Afshar; Saeid Ghavami; Alessandra Ghigo; Manosij Ghosh; Georgios Giamas; Claudia Giampietri; Alexandra Giatromanolaki; Gary E Gibson; Spencer B Gibson; Vanessa Ginet; Edward Giniger; Carlotta Giorgi; Henrique Girao; Stephen E Girardin; Mridhula Giridharan; Sandy Giuliano; Cecilia Giulivi; Sylvie Giuriato; Julien Giustiniani; Alexander Gluschko; Veit Goder; Alexander Goginashvili; Jakub Golab; David C Goldstone; Anna Golebiewska; Luciana R Gomes; Rodrigo Gomez; Rubén Gómez-Sánchez; Maria Catalina Gomez-Puerto; Raquel Gomez-Sintes; Qingqiu Gong; Felix M Goni; Javier González-Gallego; Tomas Gonzalez-Hernandez; Rosa A Gonzalez-Polo; Jose A Gonzalez-Reyes; Patricia González-Rodríguez; Ing Swie Goping; Marina S Gorbatyuk; Nikolai V Gorbunov; Kıvanç Görgülü; Roxana M Gorojod; Sharon M Gorski; Sandro Goruppi; Cecilia Gotor; Roberta A Gottlieb; Illana Gozes; Devrim Gozuacik; Martin Graef; Markus H Gräler; Veronica Granatiero; Daniel Grasso; Joshua P Gray; Douglas R Green; Alexander Greenhough; Stephen L Gregory; Edward F Griffin; Mark W Grinstaff; Frederic Gros; Charles Grose; Angelina S Gross; Florian Gruber; Paolo Grumati; Tilman Grune; Xueyan Gu; Jun-Lin Guan; Carlos M Guardia; Kishore Guda; Flora Guerra; Consuelo Guerri; Prasun Guha; Carlos Guillén; Shashi Gujar; Anna Gukovskaya; Ilya Gukovsky; Jan Gunst; Andreas Günther; Anyonya R Guntur; Chuanyong Guo; Chun Guo; Hongqing Guo; Lian-Wang Guo; Ming Guo; Pawan Gupta; Shashi Kumar Gupta; Swapnil Gupta; Veer Bala Gupta; Vivek Gupta; Asa B Gustafsson; David D Gutterman; Ranjitha H B; Annakaisa Haapasalo; James E Haber; Aleksandra Hać; Shinji Hadano; Anders J Hafrén; Mansour Haidar; Belinda S Hall; Gunnel Halldén; Anne Hamacher-Brady; Andrea Hamann; Maho Hamasaki; Weidong Han; Malene Hansen; Phyllis I Hanson; Zijian Hao; Masaru Harada; Ljubica Harhaji-Trajkovic; Nirmala Hariharan; Nigil Haroon; James Harris; Takafumi Hasegawa; Noor Hasima Nagoor; Jeffrey A Haspel; Volker Haucke; Wayne D Hawkins; Bruce A Hay; Cole M Haynes; Soren B Hayrabedyan; Thomas S Hays; Congcong He; Qin He; Rong-Rong He; You-Wen He; Yu-Ying He; Yasser Heakal; Alexander M Heberle; J Fielding Hejtmancik; Gudmundur Vignir Helgason; Vanessa Henkel; Marc Herb; Alexander Hergovich; Anna Herman-Antosiewicz; Agustín Hernández; Carlos Hernandez; Sergio Hernandez-Diaz; Virginia Hernandez-Gea; Amaury Herpin; Judit Herreros; Javier H Hervás; Daniel Hesselson; Claudio Hetz; Volker T Heussler; Yujiro Higuchi; Sabine Hilfiker; Joseph A Hill; William S Hlavacek; Emmanuel A Ho; Idy H T Ho; Philip Wing-Lok Ho; Shu-Leong Ho; Wan Yun Ho; G Aaron Hobbs; Mark Hochstrasser; Peter H M Hoet; Daniel Hofius; Paul Hofman; Annika Höhn; Carina I Holmberg; Jose R Hombrebueno; Chang-Won Hong Yi-Ren Hong; Lora V Hooper; Thorsten Hoppe; Rastislav Horos; Yujin Hoshida; I-Lun Hsin; Hsin-Yun Hsu; Bing Hu; Dong Hu; Li-Fang Hu; Ming Chang Hu; Ronggui Hu; Wei Hu; Yu-Chen Hu; Zhuo-Wei Hu; Fang Hua; Jinlian Hua; Yingqi Hua; Chongmin Huan; Canhua Huang; Chuanshu Huang; Chuanxin Huang; Chunling Huang; Haishan Huang; Kun Huang; Michael L H Huang; Rui Huang; Shan Huang; Tianzhi Huang; Xing Huang; Yuxiang Jack Huang; Tobias B Huber; Virginie Hubert; Christian A Hubner; Stephanie M Hughes; William E Hughes; Magali Humbert; Gerhard Hummer; James H Hurley; Sabah Hussain; Salik Hussain; Patrick J Hussey; Martina Hutabarat; Hui-Yun Hwang; Seungmin Hwang; Antonio Ieni; Fumiyo Ikeda; Yusuke Imagawa; Yuzuru Imai; Carol Imbriano; Masaya Imoto; Denise M Inman; Ken Inoki; Juan Iovanna; Renato V Iozzo; Giuseppe Ippolito; Javier E Irazoqui; Pablo Iribarren; Mohd Ishaq; Makoto Ishikawa; Nestor Ishimwe; Ciro Isidoro; Nahed Ismail; Shohreh Issazadeh-Navikas; Eisuke Itakura; Daisuke Ito; Davor Ivankovic; Saška Ivanova; Anand Krishnan V Iyer; José M Izquierdo; Masanori Izumi; Marja Jäättelä; Majid Sakhi Jabir; William T Jackson; Nadia Jacobo-Herrera; Anne-Claire Jacomin; Elise Jacquin; Pooja Jadiya; Hartmut Jaeschke; Chinnaswamy Jagannath; Arjen J Jakobi; Johan Jakobsson; Bassam Janji; Pidder Jansen-Dürr; Patric J Jansson; Jonathan Jantsch; Sławomir Januszewski; Alagie Jassey; Steve Jean; Hélène Jeltsch-David; Pavla Jendelova; Andreas Jenny; Thomas E Jensen; Niels Jessen; Jenna L Jewell; Jing Ji; Lijun Jia; Rui Jia; Liwen Jiang; Qing Jiang; Richeng Jiang; Teng Jiang; Xuejun Jiang; Yu Jiang; Maria Jimenez-Sanchez; Eun-Jung Jin; Fengyan Jin; Hongchuan Jin; Li Jin; Luqi Jin; Meiyan Jin; Si Jin; Eun-Kyeong Jo; Carine Joffre; Terje Johansen; Gail V W Johnson; Simon A Johnston; Eija Jokitalo; Mohit Kumar Jolly; Leo A B Joosten; Joaquin Jordan; Bertrand Joseph; Dianwen Ju; Jeong-Sun Ju; Jingfang Ju; Esmeralda Juárez; Delphine Judith; Gábor Juhász; Youngsoo Jun; Chang Hwa Jung; Sung-Chul Jung; Yong Keun Jung; Heinz Jungbluth; Johannes Jungverdorben; Steffen Just; Kai Kaarniranta; Allen Kaasik; Tomohiro Kabuta; Daniel Kaganovich; Alon Kahana; Renate Kain; Shinjo Kajimura; Maria Kalamvoki; Manjula Kalia; Danuta S Kalinowski; Nina Kaludercic; Ioanna Kalvari; Joanna Kaminska; Vitaliy O Kaminskyy; Hiromitsu Kanamori; Keizo Kanasaki; Chanhee Kang; Rui Kang; Sang Sun Kang; Senthilvelrajan Kaniyappan; Tomotake Kanki; Thirumala-Devi Kanneganti; Anumantha G Kanthasamy; Arthi Kanthasamy; Marc Kantorow; Orsolya Kapuy; Michalis V Karamouzis; Md Razaul Karim; Parimal Karmakar; Rajesh G Katare; Masaru Kato; Stefan H E Kaufmann; Anu Kauppinen; Gur P Kaushal; Susmita Kaushik; Kiyoshi Kawasaki; Kemal Kazan; Po-Yuan Ke; Damien J Keating; Ursula Keber; John H Kehrl; Kate E Keller; Christian W Keller; Jongsook Kim Kemper; Candia M Kenific; Oliver Kepp; Stephanie Kermorgant; Andreas Kern; Robin Ketteler; Tom G Keulers; Boris Khalfin; Hany Khalil; Bilon Khambu; Shahid Y Khan; Vinoth Kumar Megraj Khandelwal; Rekha Khandia; Widuri Kho; Noopur V Khobrekar; Sataree Khuansuwan; Mukhran Khundadze; Samuel A Killackey; Dasol Kim; Deok Ryong Kim; Do-Hyung Kim; Dong-Eun Kim; Eun Young Kim; Eun-Kyoung Kim; Hak-Rim Kim; Hee-Sik Kim; Jeong Hun Kim; Jin Kyung Kim; Jin-Hoi Kim; Joungmok Kim; Ju Hwan Kim; Keun Il Kim; Peter K Kim; Seong-Jun Kim; Scot R Kimball; Adi Kimchi; Alec C Kimmelman; Tomonori Kimura; Matthew A King; Kerri J Kinghorn; Conan G Kinsey; Vladimir Kirkin; Lorrie A Kirshenbaum; Sergey L Kiselev; Shuji Kishi; Katsuhiko Kitamoto; Yasushi Kitaoka; Kaio Kitazato; Richard N Kitsis; Josef T Kittler; Ole Kjaerulff; Peter S Klein; Thomas Klopstock; Jochen Klucken; Helene Knævelsrud; Roland L Knorr; Ben C B Ko; Fred Ko; Jiunn-Liang Ko; Hotaka Kobayashi; Satoru Kobayashi; Ina Koch; Jan C Koch; Ulrich Koenig; Donat Kögel; Young Ho Koh; Masato Koike; Sepp D Kohlwein; Nur M Kocaturk; Masaaki Komatsu; Jeannette König; Toru Kono; Benjamin T Kopp; Tamas Korcsmaros; Gözde Korkmaz; Viktor I Korolchuk; Mónica Suárez Korsnes; Ali Koskela; Janaiah Kota; Yaichiro Kotake; Monica L Kotler; Yanjun Kou; Michael I Koukourakis; Evangelos Koustas; Attila L Kovacs; Tibor Kovács; Daisuke Koya; Tomohiro Kozako; Claudine Kraft; Dimitri Krainc; Helmut Krämer; Anna D Krasnodembskaya; Carole Kretz-Remy; Guido Kroemer; Nicholas T Ktistakis; Kazuyuki Kuchitsu; Sabine Kuenen; Lars Kuerschner; Thomas Kukar; Ajay Kumar; Ashok Kumar; Deepak Kumar; Dhiraj Kumar; Sharad Kumar; Shinji Kume; Caroline Kumsta; Chanakya N Kundu; Mondira Kundu; Ajaikumar B Kunnumakkara; Lukasz Kurgan; Tatiana G Kutateladze; Ozlem Kutlu; SeongAe Kwak; Ho Jeong Kwon; Taeg Kyu Kwon; Yong Tae Kwon; Irene Kyrmizi; Albert La Spada; Patrick Labonté; Sylvain Ladoire; Ilaria Laface; Frank Lafont; Diane C Lagace; Vikramjit Lahiri; Zhibing Lai; Angela S Laird; Aparna Lakkaraju; Trond Lamark; Sheng-Hui Lan; Ane Landajuela; Darius J R Lane; Jon D Lane; Charles H Lang; Carsten Lange; Ülo Langel; Rupert Langer; Pierre Lapaquette; Jocelyn Laporte; Nicholas F LaRusso; Isabel Lastres-Becker; Wilson Chun Yu Lau; Gordon W Laurie; Sergio Lavandero; Betty Yuen Kwan Law; Helen Ka-Wai Law; Rob Layfield; Weidong Le; Herve Le Stunff; Alexandre Y Leary; Jean-Jacques Lebrun; Lionel Y W Leck; Jean-Philippe Leduc-Gaudet; Changwook Lee; Chung-Pei Lee; Da-Hye Lee; Edward B Lee; Erinna F Lee; Gyun Min Lee; He-Jin Lee; Heung Kyu Lee; Jae Man Lee; Jason S Lee; Jin-A Lee; Joo-Yong Lee; Jun Hee Lee; Michael Lee; Min Goo Lee; Min Jae Lee; Myung-Shik Lee; Sang Yoon Lee; Seung-Jae Lee; Stella Y Lee; Sung Bae Lee; Won Hee Lee; Ying-Ray Lee; Yong-Ho Lee; Youngil Lee; Christophe Lefebvre; Renaud Legouis; Yu L Lei; Yuchen Lei; Sergey Leikin; Gerd Leitinger; Leticia Lemus; Shuilong Leng; Olivia Lenoir; Guido Lenz; Heinz Josef Lenz; Paola Lenzi; Yolanda León; Andréia M Leopoldino; Christoph Leschczyk; Stina Leskelä; Elisabeth Letellier; Chi-Ting Leung; Po Sing Leung; Jeremy S Leventhal; Beth Levine; Patrick A Lewis; Klaus Ley; Bin Li; Da-Qiang Li; Jianming Li; Jing Li; Jiong Li; Ke Li; Liwu Li; Mei Li; Min Li; Min Li; Ming Li; Mingchuan Li; Pin-Lan Li; Ming-Qing Li; Qing Li; Sheng Li; Tiangang Li; Wei Li; Wenming Li; Xue Li; Yi-Ping Li; Yuan Li; Zhiqiang Li; Zhiyong Li; Zhiyuan Li; Jiqin Lian; Chengyu Liang; Qiangrong Liang; Weicheng Liang; Yongheng Liang; YongTian Liang; Guanghong Liao; Lujian Liao; Mingzhi Liao; Yung-Feng Liao; Mariangela Librizzi; Pearl P Y Lie; Mary A Lilly; Hyunjung J Lim; Thania R R Lima; Federica Limana; Chao Lin; Chih-Wen Lin; Dar-Shong Lin; Fu-Cheng Lin; Jiandie D Lin; Kurt M Lin; Kwang-Huei Lin; Liang-Tzung Lin; Pei-Hui Lin; Qiong Lin; Shaofeng Lin; Su-Ju Lin; Wenyu Lin; Xueying Lin; Yao-Xin Lin; Yee-Shin Lin; Rafael Linden; Paula Lindner; Shuo-Chien Ling; Paul Lingor; Amelia K Linnemann; Yih-Cherng Liou; Marta M Lipinski; Saška Lipovšek; Vitor A Lira; Natalia Lisiak; Paloma B Liton; Chao Liu; Ching-Hsuan Liu; Chun-Feng Liu; Cui Hua Liu; Fang Liu; Hao Liu; Hsiao-Sheng Liu; Hua-Feng Liu; Huifang Liu; Jia Liu; Jing Liu; Julia Liu; Leyuan Liu; Longhua Liu; Meilian Liu; Qin Liu; Wei Liu; Wende Liu; Xiao-Hong Liu; Xiaodong Liu; Xingguo Liu; Xu Liu; Xuedong Liu; Yanfen Liu; Yang Liu; Yang Liu; Yueyang Liu; Yule Liu; J Andrew Livingston; Gerard Lizard; Jose M Lizcano; Senka Ljubojevic-Holzer; Matilde E LLeonart; David Llobet-Navàs; Alicia Llorente; Chih Hung Lo; Damián Lobato-Márquez; Qi Long; Yun Chau Long; Ben Loos; Julia A Loos; Manuela G López; Guillermo López-Doménech; José Antonio López-Guerrero; Ana T López-Jiménez; Óscar López-Pérez; Israel López-Valero; Magdalena J Lorenowicz; Mar Lorente; Peter Lorincz; Laura Lossi; Sophie Lotersztajn; Penny E Lovat; Jonathan F Lovell; Alenka Lovy; Péter Lőw; Guang Lu; Haocheng Lu; Jia-Hong Lu; Jin-Jian Lu; Mengji Lu; Shuyan Lu; Alessandro Luciani; John M Lucocq; Paula Ludovico; Micah A Luftig; Morten Luhr; Diego Luis-Ravelo; Julian J Lum; Liany Luna-Dulcey; Anders H Lund; Viktor K Lund; Jan D Lünemann; Patrick Lüningschrör; Honglin Luo; Rongcan Luo; Shouqing Luo; Zhi Luo; Claudio Luparello; Bernhard Lüscher; Luan Luu; Alex Lyakhovich; Konstantin G Lyamzaev; Alf Håkon Lystad; Lyubomyr Lytvynchuk; Alvin C Ma; Changle Ma; Mengxiao Ma; Ning-Fang Ma; Quan-Hong Ma; Xinliang Ma; Yueyun Ma; Zhenyi Ma; Ormond A MacDougald; Fernando Macian; Gustavo C MacIntosh; Jeffrey P MacKeigan; Kay F Macleod; Sandra Maday; Frank Madeo; Muniswamy Madesh; Tobias Madl; Julio Madrigal-Matute; Akiko Maeda; Yasuhiro Maejima; Marta Magarinos; Poornima Mahavadi; Emiliano Maiani; Kenneth Maiese; Panchanan Maiti; Maria Chiara Maiuri; Barbara Majello; Michael B Major; Elena Makareeva; Fayaz Malik; Karthik Mallilankaraman; Walter Malorni; Alina Maloyan; Najiba Mammadova; Gene Chi Wai Man; Federico Manai; Joseph D Mancias; Eva-Maria Mandelkow; Michael A Mandell; Angelo A Manfredi; Masoud H Manjili; Ravi Manjithaya; Patricio Manque; Bella B Manshian; Raquel Manzano; Claudia Manzoni; Kai Mao; Cinzia Marchese; Sandrine Marchetti; Anna Maria Marconi; Fabrizio Marcucci; Stefania Mardente; Olga A Mareninova; Marta Margeta; Muriel Mari; Sara Marinelli; Oliviero Marinelli; Guillermo Mariño; Sofia Mariotto; Richard S Marshall; Mark R Marten; Sascha Martens; Alexandre P J Martin; Katie R Martin; Sara Martin; Shaun Martin; Adrián Martín-Segura; Miguel A Martín-Acebes; Inmaculada Martin-Burriel; Marcos Martin-Rincon; Paloma Martin-Sanz; José A Martina; Wim Martinet; Aitor Martinez; Ana Martinez; Jennifer Martinez; Moises Martinez Velazquez; Nuria Martinez-Lopez; Marta Martinez-Vicente; Daniel O Martins; Joilson O Martins; Waleska K Martins; Tania Martins-Marques; Emanuele Marzetti; Shashank Masaldan; Celine Masclaux-Daubresse; Douglas G Mashek; Valentina Massa; Lourdes Massieu; Glenn R Masson; Laura Masuelli; Anatoliy I Masyuk; Tetyana V Masyuk; Paola Matarrese; Ander Matheu; Satoaki Matoba; Sachiko Matsuzaki; Pamela Mattar; Alessandro Matte; Domenico Mattoscio; José L Mauriz; Mario Mauthe; Caroline Mauvezin; Emanual Maverakis; Paola Maycotte; Johanna Mayer; Gianluigi Mazzoccoli; Cristina Mazzoni; Joseph R Mazzulli; Nami McCarty; Christine McDonald; Mitchell R McGill; Sharon L McKenna; BethAnn McLaughlin; Fionn McLoughlin; Mark A McNiven; Thomas G McWilliams; Fatima Mechta-Grigoriou; Tania Catarina Medeiros; Diego L Medina; Lynn A Megeney; Klara Megyeri; Maryam Mehrpour; Jawahar L Mehta; Alfred J Meijer; Annemarie H Meijer; Jakob Mejlvang; Alicia Meléndez; Annette Melk; Gonen Memisoglu; Alexandrina F Mendes; Delong Meng; Fei Meng; Tian Meng; Rubem Menna-Barreto; Manoj B Menon; Carol Mercer; Anne E Mercier; Jean-Louis Mergny; Adalberto Merighi; Seth D Merkley; Giuseppe Merla; Volker Meske; Ana Cecilia Mestre; Shree Padma Metur; Christian Meyer; Hemmo Meyer; Wenyi Mi; Jeanne Mialet-Perez; Junying Miao; Lucia Micale; Yasuo Miki; Enrico Milan; Małgorzata Milczarek; Dana L Miller; Samuel I Miller; Silke Miller; Steven W Millward; Ira Milosevic; Elena A Minina; Hamed Mirzaei; Hamid Reza Mirzaei; Mehdi Mirzaei; Amit Mishra; Nandita Mishra; Paras Kumar Mishra; Maja Misirkic Marjanovic; Roberta Misasi; Amit Misra; Gabriella Misso; Claire Mitchell; Geraldine Mitou; Tetsuji Miura; Shigeki Miyamoto; Makoto Miyazaki; Mitsunori Miyazaki; Taiga Miyazaki; Keisuke Miyazawa; Noboru Mizushima; Trine H Mogensen; Baharia Mograbi; Reza Mohammadinejad; Yasir Mohamud; Abhishek Mohanty; Sipra Mohapatra; Torsten Möhlmann; Asif Mohmmed; Anna Moles; Kelle H Moley; Maurizio Molinari; Vincenzo Mollace; Andreas Buch Møller; Bertrand Mollereau; Faustino Mollinedo; Costanza Montagna; Mervyn J Monteiro; Andrea Montella; L Ruth Montes; Barbara Montico; Vinod K Mony; Giacomo Monzio Compagnoni; Michael N Moore; Mohammad A Moosavi; Ana L Mora; Marina Mora; David Morales-Alamo; Rosario Moratalla; Paula I Moreira; Elena Morelli; Sandra Moreno; Daniel Moreno-Blas; Viviana Moresi; Benjamin Morga; Alwena H Morgan; Fabrice Morin; Hideaki Morishita; Orson L Moritz; Mariko Moriyama; Yuji Moriyasu; Manuela Morleo; Eugenia Morselli; Jose F Moruno-Manchon; Jorge Moscat; Serge Mostowy; Elisa Motori; Andrea Felinto Moura; Naima Moustaid-Moussa; Maria Mrakovcic; Gabriel Muciño-Hernández; Anupam Mukherjee; Subhadip Mukhopadhyay; Jean M Mulcahy Levy; Victoriano Mulero; Sylviane Muller; Christian Münch; Ashok Munjal; Pura Munoz-Canoves; Teresa Muñoz-Galdeano; Christian Münz; Tomokazu Murakawa; Claudia Muratori; Brona M Murphy; J Patrick Murphy; Aditya Murthy; Timo T Myöhänen; Indira U Mysorekar; Jennifer Mytych; Seyed Mohammad Nabavi; Massimo Nabissi; Péter Nagy; Jihoon Nah; Aimable Nahimana; Ichiro Nakagawa; Ken Nakamura; Hitoshi Nakatogawa; Shyam S Nandi; Meera Nanjundan; Monica Nanni; Gennaro Napolitano; Roberta Nardacci; Masashi Narita; Melissa Nassif; Ilana Nathan; Manabu Natsumeda; Ryno J Naude; Christin Naumann; Olaia Naveiras; Fatemeh Navid; Steffan T Nawrocki; Taras Y Nazarko; Francesca Nazio; Florentina Negoita; Thomas Neill; Amanda L Neisch; Luca M Neri; Mihai G Netea; Patrick Neubert; Thomas P Neufeld; Dietbert Neumann; Albert Neutzner; Phillip T Newton; Paul A Ney; Ioannis P Nezis; Charlene C W Ng; Tzi Bun Ng; Hang T T Nguyen; Long T Nguyen; Hong-Min Ni; Clíona Ní Cheallaigh; Zhenhong Ni; M Celeste Nicolao; Francesco Nicoli; Manuel Nieto-Diaz; Per Nilsson; Shunbin Ning; Rituraj Niranjan; Hiroshi Nishimune; Mireia Niso-Santano; Ralph A Nixon; Annalisa Nobili; Clevio Nobrega; Takeshi Noda; Uxía Nogueira-Recalde; Trevor M Nolan; Ivan Nombela; Ivana Novak; Beatriz Novoa; Takashi Nozawa; Nobuyuki Nukina; Carmen Nussbaum-Krammer; Jesper Nylandsted; Tracey R O'Donovan; Seónadh M O'Leary; Eyleen J O'Rourke; Mary P O'Sullivan; Timothy E O'Sullivan; Salvatore Oddo; Ina Oehme; Michinaga Ogawa; Eric Ogier-Denis; Margret H Ogmundsdottir; Besim Ogretmen; Goo Taeg Oh; Seon-Hee Oh; Young J Oh; Takashi Ohama; Yohei Ohashi; Masaki Ohmuraya; Vasileios Oikonomou; Rani Ojha; Koji Okamoto; Hitoshi Okazawa; Masahide Oku; Sara Oliván; Jorge M A Oliveira; Michael Ollmann; James A Olzmann; Shakib Omari; M Bishr Omary; Gizem Önal; Martin Ondrej; Sang-Bing Ong; Sang-Ging Ong; Anna Onnis; Juan A Orellana; Sara Orellana-Muñoz; Maria Del Mar Ortega-Villaizan; Xilma R Ortiz-Gonzalez; Elena Ortona; Heinz D Osiewacz; Abdel-Hamid K Osman; Rosario Osta; Marisa S Otegui; Kinya Otsu; Christiane Ott; Luisa Ottobrini; Jing-Hsiung James Ou; Tiago F Outeiro; Inger Oynebraten; Melek Ozturk; Gilles Pagès; Susanta Pahari; Marta Pajares; Utpal B Pajvani; Rituraj Pal; Simona Paladino; Nicolas Pallet; Michela Palmieri; Giuseppe Palmisano; Camilla Palumbo; Francesco Pampaloni; Lifeng Pan; Qingjun Pan; Wenliang Pan; Xin Pan; Ganna Panasyuk; Rahul Pandey; Udai B Pandey; Vrajesh Pandya; Francesco Paneni; Shirley Y Pang; Elisa Panzarini; Daniela L Papademetrio; Elena Papaleo; Daniel Papinski; Diana Papp; Eun Chan Park; Hwan Tae Park; Ji-Man Park; Jong-In Park; Joon Tae Park; Junsoo Park; Sang Chul Park; Sang-Youel Park; Abraham H Parola; Jan B Parys; Adrien Pasquier; Benoit Pasquier; João F Passos; Nunzia Pastore; Hemal H Patel; Daniel Patschan; Sophie Pattingre; Gustavo Pedraza-Alva; Jose Pedraza-Chaverri; Zully Pedrozo; Gang Pei; Jianming Pei; Hadas Peled-Zehavi; Joaquín M Pellegrini; Joffrey Pelletier; Miguel A Peñalva; Di Peng; Ying Peng; Fabio Penna; Maria Pennuto; Francesca Pentimalli; Cláudia Mf Pereira; Gustavo J S Pereira; Lilian C Pereira; Luis Pereira de Almeida; Nirma D Perera; Ángel Pérez-Lara; Ana B Perez-Oliva; María Esther Pérez-Pérez; Palsamy Periyasamy; Andras Perl; Cristiana Perrotta; Ida Perrotta; Richard G Pestell; Morten Petersen; Irina Petrache; Goran Petrovski; Thorsten Pfirrmann; Astrid S Pfister; Jennifer A Philips; Huifeng Pi; Anna Picca; Alicia M Pickrell; Sandy Picot; Giovanna M Pierantoni; Marina Pierdominici; Philippe Pierre; Valérie Pierrefite-Carle; Karolina Pierzynowska; Federico Pietrocola; Miroslawa Pietruczuk; Claudio Pignata; Felipe X Pimentel-Muiños; Mario Pinar; Roberta O Pinheiro; Ronit Pinkas-Kramarski; Paolo Pinton; Karolina Pircs; Sujan Piya; Paola Pizzo; Theo S Plantinga; Harald W Platta; Ainhoa Plaza-Zabala; Markus Plomann; Egor Y Plotnikov; Helene Plun-Favreau; Ryszard Pluta; Roger Pocock; Stefanie Pöggeler; Christian Pohl; Marc Poirot; Angelo Poletti; Marisa Ponpuak; Hana Popelka; Blagovesta Popova; Helena Porta; Soledad Porte Alcon; Eliana Portilla-Fernandez; Martin Post; Malia B Potts; Joanna Poulton; Ted Powers; Veena Prahlad; Tomasz K Prajsnar; Domenico Praticò; Rosaria Prencipe; Muriel Priault; Tassula Proikas-Cezanne; Vasilis J Promponas; Christopher G Proud; Rosa Puertollano; Luigi Puglielli; Thomas Pulinilkunnil; Deepika Puri; Rajat Puri; Julien Puyal; Xiaopeng Qi; Yongmei Qi; Wenbin Qian; Lei Qiang; Yu Qiu; Joe Quadrilatero; Jorge Quarleri; Nina Raben; Hannah Rabinowich; Debora Ragona; Michael J Ragusa; Nader Rahimi; Marveh Rahmati; Valeria Raia; Nuno Raimundo; Namakkal-Soorappan Rajasekaran; Sriganesh Ramachandra Rao; Abdelhaq Rami; Ignacio Ramírez-Pardo; David B Ramsden; Felix Randow; Pundi N Rangarajan; Danilo Ranieri; Hai Rao; Lang Rao; Rekha Rao; Sumit Rathore; J Arjuna Ratnayaka; Edward A Ratovitski; Palaniyandi Ravanan; Gloria Ravegnini; Swapan K Ray; Babak Razani; Vito Rebecca; Fulvio Reggiori; Anne Régnier-Vigouroux; Andreas S Reichert; David Reigada; Jan H Reiling; Theo Rein; Siegfried Reipert; Rokeya Sultana Rekha; Hongmei Ren; Jun Ren; Weichao Ren; Tristan Renault; Giorgia Renga; Karen Reue; Kim Rewitz; Bruna Ribeiro de Andrade Ramos; S Amer Riazuddin; Teresa M Ribeiro-Rodrigues; Jean-Ehrland Ricci; Romeo Ricci; Victoria Riccio; Des R Richardson; Yasuko Rikihisa; Makarand V Risbud; Ruth M Risueño; Konstantinos Ritis; Salvatore Rizza; Rosario Rizzuto; Helen C Roberts; Luke D Roberts; Katherine J Robinson; Maria Carmela Roccheri; Stephane Rocchi; George G Rodney; Tiago Rodrigues; Vagner Ramon Rodrigues Silva; Amaia Rodriguez; Ruth Rodriguez-Barrueco; Nieves Rodriguez-Henche; Humberto Rodriguez-Rocha; Jeroen Roelofs; Robert S Rogers; Vladimir V Rogov; Ana I Rojo; Krzysztof Rolka; Vanina Romanello; Luigina Romani; Alessandra Romano; Patricia S Romano; David Romeo-Guitart; Luis C Romero; Montserrat Romero; Joseph C Roney; Christopher Rongo; Sante Roperto; Mathias T Rosenfeldt; Philip Rosenstiel; Anne G Rosenwald; Kevin A Roth; Lynn Roth; Steven Roth; Kasper M A Rouschop; Benoit D Roussel; Sophie Roux; Patrizia Rovere-Querini; Ajit Roy; Aurore Rozieres; Diego Ruano; David C Rubinsztein; Maria P Rubtsova; Klaus Ruckdeschel; Christoph Ruckenstuhl; Emil Rudolf; Rüdiger Rudolf; Alessandra Ruggieri; Avnika Ashok Ruparelia; Paola Rusmini; Ryan R Russell; Gian Luigi Russo; Maria Russo; Rossella Russo; Oxana O Ryabaya; Kevin M Ryan; Kwon-Yul Ryu; Maria Sabater-Arcis; Ulka Sachdev; Michael Sacher; Carsten Sachse; Abhishek Sadhu; Junichi Sadoshima; Nathaniel Safren; Paul Saftig; Antonia P Sagona; Gaurav Sahay; Amirhossein Sahebkar; Mustafa Sahin; Ozgur Sahin; Sumit Sahni; Nayuta Saito; Shigeru Saito; Tsunenori Saito; Ryohei Sakai; Yasuyoshi Sakai; Jun-Ichi Sakamaki; Kalle Saksela; Gloria Salazar; Anna Salazar-Degracia; Ghasem H Salekdeh; Ashok K Saluja; Belém Sampaio-Marques; Maria Cecilia Sanchez; Jose A Sanchez-Alcazar; Victoria Sanchez-Vera; Vanessa Sancho-Shimizu; J Thomas Sanderson; Marco Sandri; Stefano Santaguida; Laura Santambrogio; Magda M Santana; Giorgio Santoni; Alberto Sanz; Pascual Sanz; Shweta Saran; Marco Sardiello; Timothy J Sargeant; Apurva Sarin; Chinmoy Sarkar; Sovan Sarkar; Maria-Rosa Sarrias; Surajit Sarkar; Dipanka Tanu Sarmah; Jaakko Sarparanta; Aishwarya Sathyanarayan; Ranganayaki Sathyanarayanan; K Matthew Scaglione; Francesca Scatozza; Liliana Schaefer; Zachary T Schafer; Ulrich E Schaible; Anthony H V Schapira; Michael Scharl; Hermann M Schatzl; Catherine H Schein; Wiep Scheper; David Scheuring; Maria Vittoria Schiaffino; Monica Schiappacassi; Rainer Schindl; Uwe Schlattner; Oliver Schmidt; Roland Schmitt; Stephen D Schmidt; Ingo Schmitz; Eran Schmukler; Anja Schneider; Bianca E Schneider; Romana Schober; Alejandra C Schoijet; Micah B Schott; Michael Schramm; Bernd Schröder; Kai Schuh; Christoph Schüller; Ryan J Schulze; Lea Schürmanns; Jens C Schwamborn; Melanie Schwarten; Filippo Scialo; Sebastiano Sciarretta; Melanie J Scott; Kathleen W Scotto; A Ivana Scovassi; Andrea Scrima; Aurora Scrivo; David Sebastian; Salwa Sebti; Simon Sedej; Laura Segatori; Nava Segev; Per O Seglen; Iban Seiliez; Ekihiro Seki; Scott B Selleck; Frank W Sellke; Joshua T Selsby; Michael Sendtner; Serif Senturk; Elena Seranova; Consolato Sergi; Ruth Serra-Moreno; Hiromi Sesaki; Carmine Settembre; Subba Rao Gangi Setty; Gianluca Sgarbi; Ou Sha; John J Shacka; Javeed A Shah; Dantong Shang; Changshun Shao; Feng Shao; Soroush Sharbati; Lisa M Sharkey; Dipali Sharma; Gaurav Sharma; Kulbhushan Sharma; Pawan Sharma; Surendra Sharma; Han-Ming Shen; Hongtao Shen; Jiangang Shen; Ming Shen; Weili Shen; Zheni Shen; Rui Sheng; Zhi Sheng; Zu-Hang Sheng; Jianjian Shi; Xiaobing Shi; Ying-Hong Shi; Kahori Shiba-Fukushima; Jeng-Jer Shieh; Yohta Shimada; Shigeomi Shimizu; Makoto Shimozawa; Takahiro Shintani; Christopher J Shoemaker; Shahla Shojaei; Ikuo Shoji; Bhupendra V Shravage; Viji Shridhar; Chih-Wen Shu; Hong-Bing Shu; Ke Shui; Arvind K Shukla; Timothy E Shutt; Valentina Sica; Aleem Siddiqui; Amanda Sierra; Virginia Sierra-Torre; Santiago Signorelli; Payel Sil; Bruno J de Andrade Silva; Johnatas D Silva; Eduardo Silva-Pavez; Sandrine Silvente-Poirot; Rachel E Simmonds; Anna Katharina Simon; Hans-Uwe Simon; Matias Simons; Anurag Singh; Lalit P Singh; Rajat Singh; Shivendra V Singh; Shrawan K Singh; Sudha B Singh; Sunaina Singh; Surinder Pal Singh; Debasish Sinha; Rohit Anthony Sinha; Sangita Sinha; Agnieszka Sirko; Kapil Sirohi; Efthimios L Sivridis; Panagiotis Skendros; Aleksandra Skirycz; Iva Slaninová; Soraya S Smaili; Andrei Smertenko; Matthew D Smith; Stefaan J Soenen; Eun Jung Sohn; Sophia P M Sok; Giancarlo Solaini; Thierry Soldati; Scott A Soleimanpour; Rosa M Soler; Alexei Solovchenko; Jason A Somarelli; Avinash Sonawane; Fuyong Song; Hyun Kyu Song; Ju-Xian Song; Kunhua Song; Zhiyin Song; Leandro R Soria; Maurizio Sorice; Alexander A Soukas; Sandra-Fausia Soukup; Diana Sousa; Nadia Sousa; Paul A Spagnuolo; Stephen A Spector; M M Srinivas Bharath; Daret St Clair; Venturina Stagni; Leopoldo Staiano; Clint A Stalnecker; Metodi V Stankov; Peter B Stathopulos; Katja Stefan; Sven Marcel Stefan; Leonidas Stefanis; Joan S Steffan; Alexander Steinkasserer; Harald Stenmark; Jared Sterneckert; Craig Stevens; Veronika Stoka; Stephan Storch; Björn Stork; Flavie Strappazzon; Anne Marie Strohecker; Dwayne G Stupack; Huanxing Su; Ling-Yan Su; Longxiang Su; Ana M Suarez-Fontes; Carlos S Subauste; Selvakumar Subbian; Paula V Subirada; Ganapasam Sudhandiran; Carolyn M Sue; Xinbing Sui; Corey Summers; Guangchao Sun; Jun Sun; Kang Sun; Meng-Xiang Sun; Qiming Sun; Yi Sun; Zhongjie Sun; Karen K S Sunahara; Eva Sundberg; Katalin Susztak; Peter Sutovsky; Hidekazu Suzuki; Gary Sweeney; J David Symons; Stephen Cho Wing Sze; Nathaniel J Szewczyk; Anna Tabęcka-Łonczynska; Claudio Tabolacci; Frank Tacke; Heinrich Taegtmeyer; Marco Tafani; Mitsuo Tagaya; Haoran Tai; Stephen W G Tait; Yoshinori Takahashi; Szabolcs Takats; Priti Talwar; Chit Tam; Shing Yau Tam; Davide Tampellini; Atsushi Tamura; Chong Teik Tan; Eng-King Tan; Ya-Qin Tan; Masaki Tanaka; Motomasa Tanaka; Daolin Tang; Jingfeng Tang; Tie-Shan Tang; Isei Tanida; Zhipeng Tao; Mohammed Taouis; Lars Tatenhorst; Nektarios Tavernarakis; Allen Taylor; Gregory A Taylor; Joan M Taylor; Elena Tchetina; Andrew R Tee; Irmgard Tegeder; David Teis; Natercia Teixeira; Fatima Teixeira-Clerc; Kumsal A Tekirdag; Tewin Tencomnao; Sandra Tenreiro; Alexei V Tepikin; Pilar S Testillano; Gianluca Tettamanti; Pierre-Louis Tharaux; Kathrin Thedieck; Arvind A Thekkinghat; Stefano Thellung; Josephine W Thinwa; V P Thirumalaikumar; Sufi Mary Thomas; Paul G Thomes; Andrew Thorburn; Lipi Thukral; Thomas Thum; Michael Thumm; Ling Tian; Ales Tichy; Andreas Till; Vincent Timmerman; Vladimir I Titorenko; Sokol V Todi; Krassimira Todorova; Janne M Toivonen; Luana Tomaipitinca; Dhanendra Tomar; Cristina Tomas-Zapico; Sergej Tomić; Benjamin Chun-Kit Tong; Chao Tong; Xin Tong; Sharon A Tooze; Maria L Torgersen; Satoru Torii; Liliana Torres-López; Alicia Torriglia; Christina G Towers; Roberto Towns; Shinya Toyokuni; Vladimir Trajkovic; Donatella Tramontano; Quynh-Giao Tran; Leonardo H Travassos; Charles B Trelford; Shirley Tremel; Ioannis P Trougakos; Betty P Tsao; Mario P Tschan; Hung-Fat Tse; Tak Fu Tse; Hitoshi Tsugawa; Andrey S Tsvetkov; David A Tumbarello; Yasin Tumtas; María J Tuñón; Sandra Turcotte; Boris Turk; Vito Turk; Bradley J Turner; Richard I Tuxworth; Jessica K Tyler; Elena V Tyutereva; Yasuo Uchiyama; Aslihan Ugun-Klusek; Holm H Uhlig; Marzena Ułamek-Kozioł; Ilya V Ulasov; Midori Umekawa; Christian Ungermann; Rei Unno; Sylvie Urbe; Elisabet Uribe-Carretero; Suayib Üstün; Vladimir N Uversky; Thomas Vaccari; Maria I Vaccaro; Björn F Vahsen; Helin Vakifahmetoglu-Norberg; Rut Valdor; Maria J Valente; Ayelén Valko; Richard B Vallee; Angela M Valverde; Greet Van den Berghe; Stijn van der Veen; Luc Van Kaer; Jorg van Loosdregt; Sjoerd J L van Wijk; Wim Vandenberghe; Ilse Vanhorebeek; Marcos A Vannier-Santos; Nicola Vannini; M Cristina Vanrell; Chiara Vantaggiato; Gabriele Varano; Isabel Varela-Nieto; Máté Varga; M Helena Vasconcelos; Somya Vats; Demetrios G Vavvas; Ignacio Vega-Naredo; Silvia Vega-Rubin-de-Celis; Guillermo Velasco; Ariadna P Velázquez; Tibor Vellai; Edo Vellenga; Francesca Velotti; Mireille Verdier; Panayotis Verginis; Isabelle Vergne; Paul Verkade; Manish Verma; Patrik Verstreken; Tim Vervliet; Jörg Vervoorts; Alexandre T Vessoni; Victor M Victor; Michel Vidal; Chiara Vidoni; Otilia V Vieira; Richard D Vierstra; Sonia Viganó; Helena Vihinen; Vinoy Vijayan; Miquel Vila; Marçal Vilar; José M Villalba; Antonio Villalobo; Beatriz Villarejo-Zori; Francesc Villarroya; Joan Villarroya; Olivier Vincent; Cecile Vindis; Christophe Viret; Maria Teresa Viscomi; Dora Visnjic; Ilio Vitale; David J Vocadlo; Olga V Voitsekhovskaja; Cinzia Volonté; Mattia Volta; Marta Vomero; Clarissa Von Haefen; Marc A Vooijs; Wolfgang Voos; Ljubica Vucicevic; Richard Wade-Martins; Satoshi Waguri; Kenrick A Waite; Shuji Wakatsuki; David W Walker; Mark J Walker; Simon A Walker; Jochen Walter; Francisco G Wandosell; Bo Wang; Chao-Yung Wang; Chen Wang; Chenran Wang; Chenwei Wang; Cun-Yu Wang; Dong Wang; Fangyang Wang; Feng Wang; Fengming Wang; Guansong Wang; Han Wang; Hao Wang; Hexiang Wang; Hong-Gang Wang; Jianrong Wang; Jigang Wang; Jiou Wang; Jundong Wang; Kui Wang; Lianrong Wang; Liming Wang; Maggie Haitian Wang; Meiqing Wang; Nanbu Wang; Pengwei Wang; Peipei Wang; Ping Wang; Ping Wang; Qing Jun Wang; Qing Wang; Qing Kenneth Wang; Qiong A Wang; Wen-Tao Wang; Wuyang Wang; Xinnan Wang; Xuejun Wang; Yan Wang; Yanchang Wang; Yanzhuang Wang; Yen-Yun Wang; Yihua Wang; Yipeng Wang; Yu Wang; Yuqi Wang; Zhe Wang; Zhenyu Wang; Zhouguang Wang; Gary Warnes; Verena Warnsmann; Hirotaka Watada; Eizo Watanabe; Maxinne Watchon; Anna Wawrzyńska; Timothy E Weaver; Grzegorz Wegrzyn; Ann M Wehman; Huafeng Wei; Lei Wei; Taotao Wei; Yongjie Wei; Oliver H Weiergräber; Conrad C Weihl; Günther Weindl; Ralf Weiskirchen; Alan Wells; Runxia H Wen; Xin Wen; Antonia Werner; Beatrice Weykopf; Sally P Wheatley; J Lindsay Whitton; Alexander J Whitworth; Katarzyna Wiktorska; Manon E Wildenberg; Tom Wileman; Simon Wilkinson; Dieter Willbold; Brett Williams; Robin S B Williams; Roger L Williams; Peter R Williamson; Richard A Wilson; Beate Winner; Nathaniel J Winsor; Steven S Witkin; Harald Wodrich; Ute Woehlbier; Thomas Wollert; Esther Wong; Jack Ho Wong; Richard W Wong; Vincent Kam Wai Wong; W Wei-Lynn Wong; An-Guo Wu; Chengbiao Wu; Jian Wu; Junfang Wu; Kenneth K Wu; Min Wu; Shan-Ying Wu; Shengzhou Wu; Shu-Yan Wu; Shufang Wu; William K K Wu; Xiaohong Wu; Xiaoqing Wu; Yao-Wen Wu; Yihua Wu; Ramnik J Xavier; Hongguang Xia; Lixin Xia; Zhengyuan Xia; Ge Xiang; Jin Xiang; Mingliang Xiang; Wei Xiang; Bin Xiao; Guozhi Xiao; Hengyi Xiao; Hong-Tao Xiao; Jian Xiao; Lan Xiao; Shi Xiao; Yin Xiao; Baoming Xie; Chuan-Ming Xie; Min Xie; Yuxiang Xie; Zhiping Xie; Zhonglin Xie; Maria Xilouri; Congfeng Xu; En Xu; Haoxing Xu; Jing Xu; JinRong Xu; Liang Xu; Wen Wen Xu; Xiulong Xu; Yu Xue; Sokhna M S Yakhine-Diop; Masamitsu Yamaguchi; Osamu Yamaguchi; Ai Yamamoto; Shunhei Yamashina; Shengmin Yan; Shian-Jang Yan; Zhen Yan; Yasuo Yanagi; Chuanbin Yang; Dun-Sheng Yang; Huan Yang; Huang-Tian Yang; Hui Yang; Jin-Ming Yang; Jing Yang; Jingyu Yang; Ling Yang; Liu Yang; Ming Yang; Pei-Ming Yang; Qian Yang; Seungwon Yang; Shu Yang; Shun-Fa Yang; Wannian Yang; Wei Yuan Yang; Xiaoyong Yang; Xuesong Yang; Yi Yang; Ying Yang; Honghong Yao; Shenggen Yao; Xiaoqiang Yao; Yong-Gang Yao; Yong-Ming Yao; Takahiro Yasui; Meysam Yazdankhah; Paul M Yen; Cong Yi; Xiao-Ming Yin; Yanhai Yin; Zhangyuan Yin; Ziyi Yin; Meidan Ying; Zheng Ying; Calvin K Yip; Stephanie Pei Tung Yiu; Young H Yoo; Kiyotsugu Yoshida; Saori R Yoshii; Tamotsu Yoshimori; Bahman Yousefi; Boxuan Yu; Haiyang Yu; Jun Yu; Jun Yu; Li Yu; Ming-Lung Yu; Seong-Woon Yu; Victor C Yu; W Haung Yu; Zhengping Yu; Zhou Yu; Junying Yuan; Ling-Qing Yuan; Shilin Yuan; Shyng-Shiou F Yuan; Yanggang Yuan; Zengqiang Yuan; Jianbo Yue; Zhenyu Yue; Jeanho Yun; Raymond L Yung; David N Zacks; Gabriele Zaffagnini; Vanessa O Zambelli; Isabella Zanella; Qun S Zang; Sara Zanivan; Silvia Zappavigna; Pilar Zaragoza; Konstantinos S Zarbalis; Amir Zarebkohan; Amira Zarrouk; Scott O Zeitlin; Jialiu Zeng; Ju-Deng Zeng; Eva Žerovnik; Lixuan Zhan; Bin Zhang; Donna D Zhang; Hanlin Zhang; Hong Zhang; Hong Zhang; Honghe Zhang; Huafeng Zhang; Huaye Zhang; Hui Zhang; Hui-Ling Zhang; Jianbin Zhang; Jianhua Zhang; Jing-Pu Zhang; Kalin Y B Zhang; Leshuai W Zhang; Lin Zhang; Lisheng Zhang; Lu Zhang; Luoying Zhang; Menghuan Zhang; Peng Zhang; Sheng Zhang; Wei Zhang; Xiangnan Zhang; Xiao-Wei Zhang; Xiaolei Zhang; Xiaoyan Zhang; Xin Zhang; Xinxin Zhang; Xu Dong Zhang; Yang Zhang; Yanjin Zhang; Yi Zhang; Ying-Dong Zhang; Yingmei Zhang; Yuan-Yuan Zhang; Yuchen Zhang; Zhe Zhang; Zhengguang Zhang; Zhibing Zhang; Zhihai Zhang; Zhiyong Zhang; Zili Zhang; Haobin Zhao; Lei Zhao; Shuang Zhao; Tongbiao Zhao; Xiao-Fan Zhao; Ying Zhao; Yongchao Zhao; Yongliang Zhao; Yuting Zhao; Guoping Zheng; Kai Zheng; Ling Zheng; Shizhong Zheng; Xi-Long Zheng; Yi Zheng; Zu-Guo Zheng; Boris Zhivotovsky; Qing Zhong; Ao Zhou; Ben Zhou; Cefan Zhou; Gang Zhou; Hao Zhou; Hong Zhou; Hongbo Zhou; Jie Zhou; Jing Zhou; Jing Zhou; Jiyong Zhou; Kailiang Zhou; Rongjia Zhou; Xu-Jie Zhou; Yanshuang Zhou; Yinghong Zhou; Yubin Zhou; Zheng-Yu Zhou; Zhou Zhou; Binglin Zhu; Changlian Zhu; Guo-Qing Zhu; Haining Zhu; Hongxin Zhu; Hua Zhu; Wei-Guo Zhu; Yanping Zhu; Yushan Zhu; Haixia Zhuang; Xiaohong Zhuang; Katarzyna Zientara-Rytter; Christine M Zimmermann; Elena Ziviani; Teresa Zoladek; Wei-Xing Zong; Dmitry B Zorov; Antonio Zorzano; Weiping Zou; Zhen Zou; Zhengzhi Zou; Steven Zuryn; Werner Zwerschke; Beate Brand-Saberi; X Charlie Dong; Chandra Shekar Kenchappa; Zuguo Li; Yong Lin; Shigeru Oshima; Yueguang Rong; Judith C Sluimer; Christina L Stallings; Chun-Kit Tong
Journal:  Autophagy       Date:  2021-02-08       Impact factor: 13.391

8.  Hydrogen sulphide exacerbates acute pancreatitis by over-activating autophagy via AMPK/mTOR pathway.

Authors:  Liang Ji; Le Li; Fengzhi Qu; Guangquan Zhang; Yongwei Wang; Xuewei Bai; Shangha Pan; Dongbo Xue; Gang Wang; Bei Sun
Journal:  J Cell Mol Med       Date:  2016-07-15       Impact factor: 5.310

9.  Involvement of autophagy in trypsinogen activation within the pancreatic acinar cells.

Authors:  Daisuke Hashimoto; Masaki Ohmuraya; Masahiko Hirota; Akitsugu Yamamoto; Koichi Suyama; Satoshi Ida; Yuushi Okumura; Etsuhisa Takahashi; Hiroshi Kido; Kimi Araki; Hideo Baba; Noboru Mizushima; Ken-ichi Yamamura
Journal:  J Cell Biol       Date:  2008-06-30       Impact factor: 10.539

10.  Inhibition of RIPK1-dependent regulated acinar cell necrosis provides protection against acute pancreatitis via the RIPK1/NF-κB/AQP8 pathway.

Authors:  Peng-Yu Duan; Yuan Ma; Xi-Na Li; Feng-Zhi Qu; Liang Ji; Xiao-Yu Guo; Wang-Jun Zhang; Fan Xiao; Le Li; Ji-Sheng Hu; Bei Sun; Gang Wang
Journal:  Exp Mol Med       Date:  2019-08-02       Impact factor: 8.718

View more
  1 in total

1.  Downregulation of miR-30b-5p Facilitates Chondrocyte Hypertrophy and Apoptosis via Targeting Runx2 in Steroid-Induced Osteonecrosis of the Femoral Head.

Authors:  Lishan Lin; Yaling Yu; Kangping Liu; Yixin Jiang; Zhenlei Zhou
Journal:  Int J Mol Sci       Date:  2022-09-24       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.